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GENERAL INTRODUCTION 
The rhesus monkey (Maaaaa mulatta) has a menstrual cycle fundamentally simi-
lar to that of the human female, and has been used to investigate the complex 
interrelationships between the hypothalamus, anterior pituitary, and ovary 
(1). Investigations by Knobil and co-workers, in the rhesus monkey, showed 
that the timing of the gonadotropin surge, and thus ovulation, is determined 
by the ovary, which acts as a "clock" (1). This is in contrast to e.g. rats, 
in which the brain provides a daily stimulatory signal for gonadotropin re-
lease, the timing of which is related to the light-dark cycle (2). In rats, 
the release of LH occurs between 3 and 5 p.m. on the afternoon of proestrus 
and general anasthesia during this "critical period" delays the anticipated 
LH release for 24 h (2). In the rhesus monkey, the midcycle LH and FSH surge 
cannot be blocked by general anasthesia and is not related to the light-dark 
cycle (1). So, a relative insensitivity with regard to the hypothalamic regu-
lation of the preovulatory gonadotropin release can be observed in the rhesus 
monkey. Recently, it has been suggested that the hypothalamic hormones may 
provide, in fact, nothing more than permissive maintenance of pituitary func-
tion in this species (4). Moreover, estradiol may exert its direct feedback 
effect on the anterior pituitary, since normal gonadotropin surges can be in-
duced in monkeys in which the pituitary stalk has been sectioned (5). So, the 
site and action of the positive effect of E. on gonadotropin secretion has 
been investigated in great detail in the rhesus monkey. In this species, how-
ever, the positive effect of other products of the preovulatory follicle such 
as progesterone, 17a-hydroxyprogesterone, 20a-dihydroprogesterone, and andros-
tenedione on the E -induced gonadotropin release has hardly, if at all, been 
investigated. Studies in other species suggest that these steroids may facili-
tate the E -induced gonadotropin release (6-8). Although estrogens are the 
primary trigger for the midcycle LH and FSH release in the rhesus monkey, 
other ovarian steroid hormones may modify the ratio, magnitude, timing, or 
duration of this gonadotropin release. These properties of the gonadotropin 
surge may be related to the quality of the corpus luteum function and the num-
ber of ova shed per cycle (8). 
The purpose of this thesis is: 
1) To elucidate the time course of gonadotropic and ovarian steroid hormones 
in the menstrual cycle of the rhesus monkey (Chapter I). 
2) To elucidate and characterize the positive (facilitory) effect of progesterone 
on the E_-induced gonadotropin surges (Chapter II and III). 
3) To investigate the specificity of this facilitating effect with regard to 
some other ovarian steroid hormones (Chapter IV). 
A) To investigate the effects of steroid treatment in the early and midfolli-
cular phase on subsequent hormonal patterns and cycle length (Chapter V). 
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CHAPTER I 
A Statistical Analysis of the Daily Patterns of 
Luteinizing Hormone, Follicle-Stimulating Hormone, 
Estradiol, Progesterone, 20a-Dihydroprogesterone, 
and 17oi-Hydroxyprogesterone in the Menstrual Cycle 
of the Female Rhesus Monkey. 
•Helmond FA, Simons PA, Hein PR 
University Clinic for Obstetrics and Gynecology, 
Catholic University, Nijmegen, The Netherlands 
Present address: Department of Animal Physiology, 
Agricultural University, Wageningen, The Netherlands 
Endocrinology: under submission 
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ABSTRACT 
The daily hormonal patterns of luteinizing hormone (LH), follicle-stimula­
ting hormone (FSH), estradiol (E-), and progesterone (P) were analysed in 2C 
female rhesus monkeys and the patterns of 20a-dihydroprogesterone and 17a-
hydroxyprogesterone (20DHP and 170HP respectively) in 5 monkeys. The results 
showed that the daily LH, FSH, and Ρ values were normally distributed after a 
logarithmic transformation and the daily E values after a square root trans­
formation. It is assumed that 20DHP and 170HP values follow a lognormal dis­
tribution. The LH pattern is steady throughout the cycle except for the values 
at the day before (-1), after (+1), and of the LH peak (0). FSH levels declin­
ed gradually during the follicular phase. The FSH peak occurs at the same day 
as for LH. The lowest FSH levels were found in the middle third of the luteal 
phase. Thereafter, FSH levels increased gradually to the same values as observ­
ed at the first day of the cycle. The first day showing FSH concentrations 
significantly higher than those at day +8 was day +13. The E, values increased 
progressively during the follicular phase in all monkeys and reached a peak 
at day -1 (10/20) or at day 0 (10/20). The first day showing E levels signi­
ficantly higher than its preceding days was day -5. The pattern of Ρ was re­
latively stable throughout the follicular phase, and the first significant 
increase could be observed at day -1. In 19 out of 20 monkeys,its highest 
value in the follicular phase could be observed at day -1 or 0. Ρ increased 
significantly in the luteal phase and reached its maximum value at day +8. The 
pattern of 20DHP was very similar to the pattern of Ρ and this resulted in a 
highly significant positive correlation between Ρ and 20DHP in all monkeys. 
Only at the day of the LH peak we did not observe consistently higher 20DHP 
values in comparison with other values in the follicular phase. The 170HP pat­
tern showed a tendency to increase during the follicular phase and reached a 
sharp peak within one day of the LH peak. The midluteal levels of 170HP were 
higher than the levels in the follicular phase but much lower than the peri-
ovulatory levels. Furthermore, we found a significant negative correlation 
between FSH and E in the follicular phase but not in the luteal phase. FSH 
could be correlated significantly negative with Ρ in the luteal phase. 170HP 
was positively correlated with LH and E in the periovulatory period. In con­
clusion, the hormonal patterns in the rhesus monkey are quite similar to the 
patterns observed in the human female with regard to the follicular phase and 
the periovulatory period. In the luteal phase,the steroid concentrations for 
Ρ and 20DHP are at a lower level and for E„ and 170HP at an even lower level. 
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The levels of LH and FSH in the luteal phase seemed relatively higher than in 
the human female, possibly as a consequence of these decreased steroid concen­
trations. In addition, it is of interest to note that in 19 out of 20 monkeys 
the Ρ concentrations at the day before and at the day of the LH peak were the 
highest concentrations of the follicular phase. So, the increasing Ρ levels in 
the late follicular phase may very well be used in the prediction of the LH 
surge. 
INTRODUCTION 
The time course of luteinizing hormone (LH), follicle-stimulating hormone 
(FSH), estradiol (E ) and progesterone (P) in the female rhesus monkey has 
been described by several authors (1-11). In all but one study (9),the number 
of animals investigated throughout the whole cycle was relatively small and 
whenever attempts were made to establish reliable criteria for the time course 
of LH, FSH, E , and Ρ during the menstrual cycle (11) these criteria were not 
analysed with statistical methods. In this study, we investigated the daily 
distribution of the LH, FSH, E , and Ρ values in 20 rhesus monkeys and analys­
ed with statistical tools the criteria of normal features of hormone secretion 
in the rhesus monkey. Since the patterns of 17a-hydroxyprogesterone (170HP) 
(4) and 20a-dihydroprogesterone (20DHP) (12-13) have not yet been well-estab­
lished, we determined, in addition, in five of these monkeys, the daily pat­
terns of the 170HP and the 20DHP values, in radioimmunoassays simultaneously 
with E and P. 
MATERIALS AND METHODS 
Twenty female rhesus monkeys (Maaaoa Mulatta) having a history of regular 
menstrual cycles were used in this study. They were housed and given general 
care as described previously (14). The menstrual cycles selected for this com­
munication were collected throughout the year, except for the summer period 
June-August. These cycles were preceded by at least one cycle of normal length 
(23-35 days). From each monkey one menstrual cycle was studied. The length 
of the cycles studied was 28.1±2.7 (SD) days (range 23-32). The length of the 
follicular phase, defined as the first day of menstruation to the day of the 
LH peak, was 11.9+2.0 days (range 8-15). The length of the luteal phase, de­
fined as the first day after the LH peak to the day before the next menstru­
ation, was 16.3±1.5 days (range 14-19). During the cycles studied the animals 
weighed between 4.5 and 7.2 kg and their age was estimated at 12.3±1.3 years 
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(range 10-15). Blood samples of 2 ml were drawn daily between 1300 and 1400 
without either physical or pharmacological restraint (14). 
All samples were analysed by RIA for their LH, FSH, E , and Ρ concentrations 
as described previously (14). In five monkeys the Ε , Ρ, 170HP, and 20DHP con­
centrations were measured in a simultaneous RIA procedure as described pre­
viously (15). The standards used for the LH and FSH RIA were LER 1056-C2 and 
LER 1909-2 respectively. 
Analysis of hormonal data 
The day of the midcycle LH peak (day 0) is the point of reference for com­
paring hormone data between and within individual cycles for all days except 
for the first three and the last four days of the menstrual cycle for which 
the first day of menstruation is the point of reference. The terms follicular 
phase, periovulatory period and luteal phase will be defined on every occasion 
in the result section. The analysis of the distribution of daily hormone val­
ues involved both a test for skewness and Geary's test for kurtosis. The sig­
nificance level for both tests was set at the 2% level, two tailed. We inves­
tigated whether after a square root- or logarithmic transformation the number 
of days showing a nonnormal distribution could be reduced. A normal (Gaussian) 
distribution was concluded for all cycle days when at least in 21 out of 28 
days (two tailed sign test, 2% level) normality could not be rejected with re­
gard to the skewness and the kurtosis of the distribution. In all further cal­
culations the data from the normal distribution will be used. For the daily 
LH, FSH, E., and Ρ values tolerance limits were calculated by means of a stat­
istical estimation of the 2.5th and the 97.5th percentile for each day (P.
 s 
and Ρ respectively) according to the method described by Rümke and Besemer 
(16). These limits have the following meaning: at the 95% confidence level, at 
most 95% of the daily hormone values can be found within these limits. These 
values will be regarded as normal values. The relation between hormones, and 
between a hormone and the day of the cycle has been analysed with a liniar re-
gression model, unless stated otherwise. The significance level of the correl-
ation coefficient has been set at the 5% level, two tailed. The sign test was 
used to investigate whether the frequency of occurrence of a positive or nega-
tive correlation coefficient was significant at the 5% level, two tailed. Dif-
ferences between hormone concentrations in the menstrual cycle have been analy-
sed with the F test for contrasts (contrast test of Scheffé) at the 5% level 
of significance. 
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RESLLTS 
The patteim of Lri (ігд. 1, top pannel) 
An analysis of the distribution of the daily values of LH showed that a log-
normal distribution could not be rejected with regard to the skewness and kur-
tosis of the distribution for all but two days On day +15 we found evidence 
for a negative skewed distribution and on day -9 there was evidence for a lep-
tokurtic distribution. The geometrical mean and the tolerance limits of the 
lognormal distribution of the daily LH values are presented in the top pannel 
of Fig 1 The tolerance limits are the inner limits of the P. . and the Ρ^η с 
of the lognormal distribution determined at the 95% confidence level. The LH 
values within these limits will be regarded as normal values 
The pattern of the LH concentrations showed steady unchanging serum concen­
trations throughout the follicular phase The first part of the follicular 
phase was not different from the second part of the follicular phase (days -11 
to -7 VS. -6 to -2, Table 1) In addition, we showed that there was an equal 
amount of positive and negative correlations between the days of the cycle 
(days -11 to -2) and the LH concentrations, resulting in a nonsignificant 
overall correlation (Table 7). The LH peak (1685±110 pg/ml) was on the average 
3.65±0.31 (SE) times the pooled follicular phase mean (range 1 74-6 95) The 
day before (-1) and the day after (+1) the LH peak were significantly increas­
ed above the pooled mean of the follicular and luteal phase respectively (Ta­
ble 1) The pattern of LH showed also in the luteal phase steady and unchang­
ing serum concentrations. The first part of the luteal phase was not different 
from the second part (days +2 to +9 vs. +10 to +16, Table 1) The number of 
positive and negative correlations too, were equally distributed when analysing 
LH us. the day of the luteal phase (Table 7). The LH concentrations in the 
follicular phase (514±47 pg/ml) seemed to be slightly lower than the concen­
trations in the luteal phase (559+49 pg/ml) (days -11 to -2 VS. +2 to +16, 
Table 1) or the concentrations of the second part of the luteal phase (days 
-11 to -2 vs. +2 to +16, Table 1) This difference, however, is minor (10%) 
and the frequency of occurrence of this difference is only 60%. 
ТПе pattern of FSH (Fig. 1, 2nd pannel) 
An analysis of the distribution of the daily values of FSH showed that a log-
normal distribution could not be rejected for all days The geometrical mean 
and the inner limits of the P. ,. and the P.7 . of the lognormal distribution 
of the daily FSH values are presented in the second pannel of Fig 1. The FSH 
13 
β .12 .16 
14 
Fig. 1. The patterns of LH, FSH, Ε , Ρ, 20DHP, and 170ΗΡ during normal menstrual 
cycles in rhesus monkeys. The geometrical mean is represented for each hormone, 
except for Ε , for which the mean after a square root transformation is repre­
sented. The day of the LH and FSH peak (day 0) is taken as the point of referen­
ce, except for the first 3 and the last 4 days, for which the first day of mens­
truation is the point of reference. The shaded apeas are the interval between 
the P, _ and the P Q 7 _ of the innerlimits of the transformed data, except for 
20DHP and 170HP, for which the shaded areas represent the 95% confidence limits 
of the geometrical mean. 
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5.71 
48.66 
4.91 
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0.07 
0.06 
ІЧ0.001 
P<0.001 
P<0.001 
?<0.001 
P<0.001 
NS. 2 
NS. 
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16/20 
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12/20 
12/20 
10/20 
10/20 
Table 1. Significance of differences between cycle days of LH, as established 
by the calculation of contrasts, and their incidence in 20 menstrual cycles. 
Contrasts between cycle days F value Significance Incidence 
+
1
 -11 to -2 vs. -1 
+ +2 to +16 VS. +1 
+ -1 and +1 vs. 0 
+ -11 to -2 vs. +2 to +16 
4· -11 to -2 vs. +10 to +16 
Ψ -11 to -7 VS. -6 to -2 
t +2 to +9 vs. +10 to +16 
'The arrow indicates whether the first part of the contrast is higher (+)-or 
lower (v) than the second part. 
¿NS. = nonsignificant 
Table 2. Significance of differences between cycle days of FSH, as established 
by the calculation of contrasts, and their incidence in 20 menstrual cycles. 
Contrasts between cycle days F value Significance Incidence 
4- 1 -6 to -2 VS. -1 
Ψ +2 to +8 us. +1 
+ -1 and +1 VS. 0 
+ -6 to -2 ve. +2 to +8 
+ -11 to -7 vs. -6 to -2 
+ +2 to +4 vs. +5 to +8 
+ +8 to +11 vs. +12 to +16 
+ +2 to +6 US. +7 to +11 
+ +7 to +11 vs. +12 to +16 
+ +8 us. +13 
'The arrow indicates whether the first part of the contrast is higher (+) or 
lower (Ψ) than the second part. 
2NS. = nonsignificant 
0.76 
6.08 
56.98 
0.49 
11.45 
2.00 
18.79 
3.85 
21.79 
3.86 
NS. 2 
P<0.001 
P<0.001 
NS. 
P<0.001 
P<0.025 
P<0.001 
P<0.001 
P<0.001 
P<0.001 
14/20 
17/20 
20/20 
11/20 
18/20 
13/20 
19/20 
15/20 
19/20 
15/20 
16 
values within these limits will be regarded as normal values. 
The pattern of the FSH concentrations showed a continuous decline throughout 
the follicular phase. In 90% of the monkeys the FSH concentration in the sec-
ond part of the follicular phase was lower than in the first part of the fol-
licular phase (days -11 to -7 VS. -6 to -2, Table 2). In addition, we showed 
that in 90% of the monkeys a negative correlation between the FSH concentra-
tions and the days of the cycle could be calculated (days -11 to -2). This in-
cidence rate (18/20) is significant (,P<0.01, two tailed sign test, Table 7). 
Correlating all FSH values with the days of the follicular phase (days -11 to 
-2) results in a highly significant negative correlation (Table 7). The FSH 
concentrations at the day before the LH peak (-1) were not significantly high-
er than at the preceding days (days -6 to -2, Table 2). The FSH concentrations 
at the day after the LH peak were significantly higher than at the following 
days (days +1 vs. +2 to +8, Table 2). The FSH peak (9.9±1.2 pg/ml) occurred at 
the same time as the LH peak and was on the average 3.63±0.32 times (range 
1.75-6.47) the pooled follicular mean. The FSH pattern in the first part of 
the luteal phase is not quite clear. We found a significant tendency to lower 
levels by analysing contrasts (days +2 to +4 VS. +5 to +8). The frequency of 
occurrence, however, is not very high (65%). We found in 15/20 monkeys a nega-
tive correlation between FSH and the days of the luteal phase (days +2 to +8) 
but this observation is not significant at the 5% level (Table 7). This part 
of the luteal phase did not show lower values than the second part of the fol-
licular phase (days -6 to -2 US. +2 to +8, Table 2). It is evident that the 
lowest FSH values could be found in the middle of the third part of the luteal 
phase (days +2 to +6 Vs. +7 to +11, and +7 to +11 VS. +12 to +16, Table 2). In 
the second part of the luteal phase (days +8 to +16) FSH increased gradually. 
This result was demonstrated by analysing contrasts (days +8 to +11 vs. +12 to 
+16, incidence 100% , Table 2) and by analysing the correlation between FSH 
concentrations and the days of the luteal phase (days +8 to +16, Table 7) 
which showed a positive sign in all monkeys. The first day showing FSH con-
trations higher than those observed at day +8 was day +13 (day +8 Vs. +13, 
Table 2). 
The pattern of £„ (Fig. 13 Srd pannel) 
An analysis of the distribution of the daily values of E showed that a nor-
mal distribution could not be rejected after a square root transformation of 
these values in all but two days; on day +11 we found evidence for a positive-
ly skewed distribution. The mean of the square root transformed daily E values 
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Table 3. Significance of differences between cycle days of Estradiol, as estab­
lished by the calculation of contrasts, and their incidence in 20 menstrual 
cycles. 
Contrasts between cycle days F value Significance Incidence 
+
1
 -11 to -7 vs. -6 to -1 
4· -11 to -6 us. -5 
4- +1 to +6 vs. +7 to +11 
+ +7 to +11 vs. +12 to +16 
ν +2 to +6 vs. +1 to +16 
The arrow indicates whether the first part of the contrast is higher (t) or 
lower (O than the second part. 
NS. = nonsignificant 
Table 4. Significance of differences between cycle days of Progesterone, as 
established by the calculation of contrasts, and their incidence in 20 mens­
trual cycles. 
68.96 
2.94 
4.74 
0.15 
6.14 
P<0.001 
F<0.001 
P<0.001 
NS. ? 
P<0.001 
19/20 
16/20 
16/20 
11/20 
18/20 
Contrasts between cycle days 
t -11 
t -11 
t -11 
+ 0 
+ -1 
f -2 
t 0 
+ +1 
A
 +7 
to -7 
to -7 
to +6 
to +11 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
-6 to -1 
-6 to -2 
-10 to -2 
-1 
-2 
-3 
+ 1 
+7 to +11 
+12 to +16 
F value 
0.28 
1.77 
0.89 
17.36 
3.83 
0.58 
0.03 
26.53 
32.16 
Significance 
NS. 
P<0.05 
NS. 
F<0.001 
P<0.001 
NS. 
NS. 
P<0.001 
P<0.001 
Incidence 
12/20 
14/20 
13/20 
17/20 
14/20 
11/20 
12/20 
19/20 
20/20 
The arrow indicates whether the first part of the contrast is higher (t) or 
lower (O than the second part. 
NS. = nonsignificant 
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and the inner limits of the Ρ . and the Ρ of the square root transformed 
normal distribution of the daily E values are presented in the third pannel 
of Fig. 1. The E values within these limits will be regarded as normal values. 
The pattern of E showed a progressive rise during the follicular phase. In 
95% of the monkeys the second part of the follicular phase was higher than the 
first part (days -11 to -7 vs. -6 to -1, Table 3). In addition, we showed that 
in all 20 monkeys a highly significant positive correlation between E and the 
day of the follicular phase (day -11 to the day of the E peak) could be cal­
culated. The use of a parabolic model instead of a linear one showed even high­
er correlation coefficients within the individual monkeys. Eighteen out of 20 
of these coefficients were significant, but when all pairs were analysed the 
correlation coefficients in both models were very much the same. The first day 
showing E values significantly higher than the preceding days, was day -5 
(days -11 to -5, Table 3). In all monkeys the E„ peakoccurred at day -1 (10/ 
20) or at day 0 (10/20) and was at least twice the pooled follicular mean. In 
90% of the monkeys a postovulatory nadir could be demonstrated (days +2 to +6 
VS. +1 to +16, Table 3). The mean E values at day +2 and +3 are in fact the 
lowest of the whole menstrual cycle. After this luteal nadir the E values 
rose again and this resulted in significantly increased E concentrations in 
the middle third of the luteal phase vs. the first third (+1 to +6 vs. +7 to 
+11, Table 3). The E concentrations in the middle third of the luteal phase 
were not significantly higher than in the last third of the luteal phase 
(days +7 to +11 vs. +12 to +16, Table 3). 
The pattern of Ρ (Fig. 1, 4th panneL) 
An analysis of the distribution of the daily values of Ρ contains one diffi­
culty namely that in the follicular phase the Ρ values are frequently below 
the detection limit of the RIA and thus deviations from a normal distribution 
can be expected in this stage of the menstrual cycle after every transforma­
tion. The best transformation proved to be the logarithmic transformation. In 
all but one day the lognormal distribution could not be rejected with regard 
to the test for skewness. On day +13,we found evidence for a negatively skew­
ed distribution. The test for kurtosis provided evidence for a tendency in the 
direction of a platykurtic distribution on the days -10, -9, -6, -5, and -2. 
In all other days the lognormal distribution could not be rejected with regard 
to the test for kurtosis. 
The pattern t>f Ρ appeared to be unchangeable during the follicular phase of the 
cycle. The first part of the follicular phase was not significantly different 
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from the second part (days -11 to -7 Vs. -6 to -1, Table 4). Day -1 belongs 
to the periovulatory period (see below) and if day -1 is discarded from the 
second part of the follicular phase, the first part of the follicular phase 
will be higher in 70% of the monkeys (days -11 to -7 vs. -6 to -2, Table 4). 
The concentration of Ρ at the first day of the menstrual cycle, suspected of 
showing residual effects from the preceding luteal phase, was in 65% of the 
monkeys higher than in the rest of the follicular phase, but this observation 
is not significant (days -11 US. -10 to -2, Table 4). The Ρ values at the day 
of the LH peak were significantly increased with respect to the values obser­
ved at the day before the LH peak (day 0 Vs. -1, Table 4). In 70% of the monk­
eys day -1 was significantly higher than day -2 (day -1 Vs. -2, Table 4). The 
highest value of the follicular phase could be observed at day 0 (16/20) or 
at day -1 (3/20). The remaining monkey showed its highest Ρ level at the first 
day of the menstrual cycle. A periovulatory diminution for Ρ was not evident 
in our study, since in only 60% of the monkeys the values at day 0 were higher 
than at day +1 (day 0 vs. +1, Table 4). A clear pattern of Ρ was found in the 
luteal phase: the concentration of Ρ in the middle third of the luteal phase 
was definitively higher than in the first third (days +1 to +6 vs. +7 to +11, 
Table 4) and the last third (days +7 to +11 vs. +12 to +16, Table 4). The mean 
Ρ value of the middle third of the luteal phase was always higher than 2 ng/ml, 
The mean Ρ value in the last third of the luteal phase was lower than 2 ng/ml 
in 17 out of 20 monkeys. 
The pattern of 20DHP (Fig. 1, Sth pannel) 
An analysis of the distribution of the daily 20DHP values has not been per­
formed because the number of observations is too small (n=5). A lognormal dis­
tribution of the 20DHP values is assumed and the geometrical mean and the 95% 
confidence levels of the mean are presented in the fifth pannel of Fig. 1. The 
pattern of 20DHP showed steady unchanging serum concentrations throughout the 
follicular phase. The first part of the follicular phase was not different 
from the second part (days -11 to -7 ys. -6 to -1, Table 5). The 20DHP concen­
tration at the first day of the menstrual cycle, however, proved to be higher 
than on the remaining days of the follicular phase (days -11 Vs. -10 to -1, 
Table 5). The 20DHP values at the day of the LH peak were significantly in­
creased with respect to day -1 in 80% of the monkeys (day 0 ys. -1, Table 5). 
In contrast to P,the highest value in the follicular phase was only in two 
monkeys at day 0, yet the values at day 0 were significantly higher than the 
average values in the follicular phase (day 0 VS. -11 to -1, Table 5). 
20 
Table 5. Significance of differences between cycle days of 20a-dihydroprogeste-
rone.as established by the calculation of contrasts, and their incidence in 5 
menstrual cycles. 
Contrasts 
Ψ
1
 -11 
+ -11 
+ 0 
+ -1 
+ 0 
+ 0 
+ +1 
+ +7 
to 
to 
to 
between cycle days 
-7 
+6 
+ 11 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
VS. 
-6 to -1 
-10 to -1 
-1 
-2 
+ 1 
-11 to -1 
+7 to +11 
+12 to +16 
F value 
0.08 
7.85 
4.98 
0 
3.29 
5.37 
116.03 
108.52 
Significance 
NS. 2 
P<0.001 
P<0.001 
NS. 
P<0.001 
P<0.001 
P<0.001 
P<0.001 
Incidence 
3/5 
3/5 
4/5 
3/5 
3/5 
4/5 
5/5 
5/5 
^The arrow indicates whether the first part of the contrast is higher (+) or 
lower (+) than the second part. 
2NS. = nonsignificant 
Table 6. Significance of differences between cycle days of 17a-hydroxyprogester-
one, as established by the calculation of contrasts, and their incidence in 5 
menstrual cycles. 
Contrasts 
fl -11 
t -11 
+ 0 
+ -1 
t 0 
t 0 
+ 0 
+ +2 
+ +7 
+ +7 
+ +2 
to 
to • 
to 
to • 
and 
between cycle days 
-7 
+6 
+ 11 
+ 11 
+3 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
vs. 
-6 to -1 
-10 to -1 
-1 
-2 
+ 1 
+2 
-11 to -1 
+7 to +11 
+12 to +16 
-11 to -1 
+4 to +12 
F value 
2.07 
0.54 
2.64 
0.04 
0.34 
14.22 
21.70 
0.44 
9.32 
4.06 
2.24 
Significance 
P<0.025 
NS. 2 
P<0.005 
NS. 
NS. 
P<0.001 
P<0.001 
NS. 
ZJ<0.001 
P<0.001 
P<0.010 
Incidence 
3/5 
3/5 
4/5 
3/5 
3/5 
4/5 
4/5 
4/5 
5/5 
4/5 
3/5 
^he arrow indicates whether the first part of the contrast is higher (-t ) or 
lower (+) than the second part. 
NS. = nonsignificant 
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Table 7. The correlations between hormones and their incidence in 20 menstrual cycles. 
Correlations between X and Y Incidence of the sign o£ the r value Sign test Analyzing all pairs 
on the indicated days and its significance in individuals 
Χ, Y Days + F<0.05 - P<0.05 Ρ value r η Ρ value 
Days, 
Days, 
Days, 
E
r 
P, 
P . : 
170HP
: 
170HP 
LH 
FSH 
E 2 
FSH 
FSH 
20DHP 
, LH 
. E , 
-11 
+2 
-11 
+ 2 
+8 
-11 
-11 
+ 2 
+ 2 
+8 
+2 
+ 1 
-4 
-4 
t o 
t o 
t o 
t o 
t o 
t o 
t o 
t o 
t o 
t o 
t o 
t o 
t o 
t o 
-2 
+ 16 
-2 
+ 8 
+ 16 
E 2 peak 
-2 
+ 16 
+8 
+ 16 
+ 16 
+ 16 
+2 
+2 
+2 to +£ 
10 
10 
2 
5 
20 
20 
2 
15 
7 
11 
2 
5 
4 
5 
4 
3 
1 
0 
0 
12 
17 
0 
2 
0 
2 
0 
5 
1 
1 
1 
10 
10 
18 
15 
0 
0 
18 
5 
13 
9 
18 
0 
1 
0 
1 
1 
2 
12 
3 
0 
0 
5 
2 
4 
0 
8 
0 
0 
0 
0 
N S . 1 
NS. 
<0.01 
NS. 
<0.01 
<0.0] 
<0.01 
NS. 
NS. 
NS. 
<0.01 
NA. 2 
NA. 
NA. 
NA. 
- 0 . 0 4 3 
- 0 . 0 9 0 
- 0 . 3 7 3 
- 0 . 1 4 1 
+ 0 . 2 2 5 
+ 0 . 5 6 6 
-0 .179 
- 0 . 0 4 4 
- 0 . 0 1 
- 0 . 1 0 7 
- 0 . 1 2 6 
+ 0 . 8 9 3 
+ 0 . 4 5 4 
+ 0 . 5 0 5 
- 0 . 3 0 2 
198 
305 
198 
140 
185 
226 
198 
305 
140 
185 
305 
96 
35 
35 
35 
NS. 
NS. 
<0.001 
NS. 
<().()! 
< 0 . 0 0 1 
<0.02 
NS. 
NS. 
NS. 
<0.05 
<0.001 
< 0 . 0 1 
< 0 . 0 1 
NS. 
NS. = nonsignificant 
2NA. = not analysed, number of observations is too small. 
The 2ÜDHP concentrations at the day after the LH peak are higher than at the 
day of the LH peak (day 0 ¿s. +1, Table 5), thus there is no evidence for a 
penovulatory diminution of 20DHP The pattern of 20DHP in the luteal phase 
is quite identical to that of P, but 20DHP runs at a lower level As holds 
true for P, 20DHP values in the middle third of the luteal phase were increas-
ed above the values in the first third (+1 to +6 OJ. +7 to +11, Table 5) and 
the last third (+7 to +11 va. +12 to +16) The mean value of the middle third 
of the luteal phase was always higher than 1 ng/ml The mean value of the last 
third of the luteal phase was always lower than 0 5 ng/ml 
The pattern of 170riP (Ьгд. 1, 6tu pannel) 
An analysis of the distribution of the daily 170HP values has not been per­
formed because the number of observations is too small (n=5) A lognormal dis­
tribution of the 170HP values is assumed and the geometrical mean and the 95% 
confidence levels of the mean are presented in the sixth pannel of Fig 1 
The pattern of the 170HP concentrations during the follicular phase showed a 
tendency to higher levels in the second part of the follicular phase The 
170HP concentrations in this part of the follicular phase were significantly 
higher than the first part (days -11 to -7 OS. -6 to -1, Table 6) The 170HP 
concentrations at the first day of the menstrual cycle were not different from 
those at the other days of the follicular phase (days -11 VS. -10 to -1, Table 
6). At the day of the LH peak,the 170HP concentrations were higher than at the 
day before (day 0 Vs. -1, Table 6) and the preceding days in the follicular 
phase (day 0 us. -11 to -1, Table 6) in 80% of the monkeys The values at day 
+1 were not significantly different from day 0 (day 0 vs. +1, Table 6) but at 
day +2 the 170HP values were significantly lower than at day 0 (day 0 VS. +2, 
Table 6) The highest 170HP values m the menstrual cycle were observed at day 
0 in three monkeys, at day -1 in one monkey and at day +1 in the renaming one 
The lowest 170HP values in the first part of the luteal phase could be found 
at the days +2 and +3 (days +2 and +3 ys. +4 to +12, Table 6) In 4 out of 5 
monkeys the middle third of the luteal phase was higher than the first third, 
but this observation was not significant (+2 to +6 Vs. +7 to +11, Table 6) 
The 170HP values in the middle third of the luteal phase were in all monkeys 
higher than those in the last third (day +7 to +11 VS. +12 to +16, Table 6) 
The 170HP values in the middle third of the luteal phase were higher than the 
values observed in the follicular phase (+7 to +11 US. -11 to -1, Table 6) 
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Correlations beLueen the hormones (Table 7) 
We investigated the relation between the hormones with a variety of models. 
In general, the linear model showed the best results and these data are pre­
sented in Table 7. In the follicular phase, we found evidence for a negative 
correlation between E and FSH in 90% of the monkeys (E vs. FSH, days -11 to 
-2, Table 7). We found no significant correlation between E and FSH in the 
whole luteal phase (E VS. FSH, days +2 to +16, Table 7) nor in any part of 
the luteal phase (days +2 to +8, and +8 to +16, Table 7). A clear correlation 
between Ρ and FSH (Ρ vs. FSH, days +2 to +16, Table 7) could be established 
in 90% of the monkeys. A highly significant and very consistent positive cor­
relation was found between Ρ and 20DHP in all monkeys throughout the whole 
cycle (P VS. 20DHP, days +1 to +16, Table 7). Only during the periovulatory 
period could 170HP be correlated significantly with LH (170HP us. LH, days -4 
to +2, Table 7) and with E (170HP vs. Ε , days -4 tô +2, Table 7). 
DISCUSSION 
The rhesus monkey has been used as an important model for endocrinological 
investigations in the human since the early work of Corner (17), who investi-
gated the relation between ovulation and menstruation in this species. Later 
on it was found that the hormonal patterns and the length of the cycle were 
in good agreement with human data (for review see Ref. 8,18). Criteria for 
normal features of LH, FSH, E , and Ρ secretion in the rhesus monkey were set 
up by Wilks et al. (11). The procedure to identify these features did not in­
volve a statistical test. The present study deals with the time course of six 
hormones in twenty female rhesus monkeys. One menstrual cycle was studied of 
each monkey. Hormone levels of LH, FSH, E and Ρ were determined in all monk­
eys and levels of 20DHP and 170HP in five monkeys. To our knowledge, we estab­
lished the first data about the daily distribution of LH, FSH, E , and Ρ in 
the rhesus monkey with the aid of statistical tools. We concluded that the 
daily LH, FSH, and Ρ values followed a lognormal distribution. The E values 
followed a normal distribution after a square root transformation. Kletzky et 
al. (28) found a lognormal distribution for LH, FSH, E,, and Ρ in the human. 
Briet (44) found a lognormal distribution for LH (analysed were days -2 to +4) 
and an equal posibility for a normal or lognormal distribution for FSH (analys­
ed were days -5 to +4) in his material in the human. The number of cycles, in 
which the 170HP and 20DHP concentrations were measured, was too small (n=5) to 
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establish the sort of normal distribution. It was assumed that these hormones 
follow a lognormal distribution (19). The acceptability of the lognormal dis­
tribution of the daily patterns of 20DHP was supported by the fact that a 
highly significant positive correlation between 20DHP and Ρ throughout the 
cycle was established in all monkeys. The establishment of the daily normal 
distribution was very helpful in the determination of the normal values for 
each hormone for each day or period of the cycle. At this point it must be 
mentioned that LH concentrations were determined with the anti-ovine LH serum-
radiolabeled ovine LH assay system (20), at the present the only RIA generally 
available and most widely used for measurement of LH in monkeys. This RIA sys­
tem crossreacts with an LH-like substance in monkey serum which seems not to 
be under the negative feedback control of estrogens (21). In comparison with 
an in vitro LH bioassay the ovine-ovine- LH RIA seems to overestimate to some 
extend the basal LH values and to underestimate the LH peak values (22,23). 
The use of a radioreceptor assay resulted in LH peaks of a lower magnitude 
than in the ovine-ovine- LH RIA (24). The difference between the in vitro LH 
bioassay and the radioreceptor assay during the period of hypersecretion of 
LH in the middle of the cycle is possibly due to an increase in the degree of 
sialysation in the LH molecule (24). The potency of LH in the in vitro bio­
assay reduces after desialysation and the potency of LH in the radioreceptor 
assay increases after desialysation (24). The "true" pattern of LH is possibly 
more like the pattern of FSH, at least when LH is measured with a specific 
rhesus LH RIA (8,25), for LH decreases at the end of the follicular phase and 
reaches a minimum in the luteal phase. We found no differences in the time 
course of LH during the follicular or luteal phase; LH concentrations were 
stable and were only significantly increased at days -1, 0, and +1. We did not 
find lower LH levels in the luteal phase as was observed in rhesus monkeys 
when a specific RIA was used. Lower LH levels in the luteal phase have also 
been reported in the human (26-29). Our results are also at variance with the 
observations of Wilks et al. (11), who used the same ovine-ovine- LH RIA sys­
tem and who found an 80% incidence rate for this phenomenon VS. 40% in our 
study. However, the difference between the LH concentrations in the follicular 
and luteal phase is very small in both studies and so it is doubtful whether 
these studies differ significantly and whether such a small difference can be 
used as a reliable criteria for the normal LH secretion in the rhesus monkey. 
The time course of FSH followed a pattern described previously by others 
(5-11). We demonstrated a clearly negative correlation of FSH with the day of 
the cycle in 90% of the monkeys in the follicular phase. In the first part of 
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the luteal phase we were not able to define a clear FSH pattern, although 
there seems to be a tendency to lower levels. This finding, did not occur at 
a high frequency within individuals. In the human FSH declines continuously 
throughout the menstrual cycle, interrupted by the midcycle FSH peak. As a 
consequence, FSH levels were found to be lower in the first part of the luteal 
phase than in the last part of the follicular phase (26-29). In our study FSH 
levels were at their lowest point in the middle third of the luteal phase. 
Then a steady rise of FSH occurred in every monkey resulting in a significantly 
increased FSH secretion from day +13 on. In a recent study (30) in the stump-
tailed monkey (Maaaaa avotoides), FSH levels were also not decreased in the 
first part of the luteal phase, on the contrary, there seemed to be evidence 
for a secondary rise of FSH 2-3 days after the LH peak, at the same time when 
E values were at their lowest point during the menstrual cycle. We also found 
that the E. levels were at their lowest point at day +2 and +3. This observa­
tion is in agreement with that of others (7-11). In our study,E increased 
thereafter slightly to a "luteal plateau". This luteal increment is quantita­
tively much less obvious than in the human (31). These E levels, lower in 
the luteal phase of the rhesus monkey than in the one of the human, may ex­
plain the difference in length of the follicular phase,(12 VS. 14 days) and 
of the luteal phase (16 Уз. 14 days) in these species (32-34). We were not 
able to find evidence for a decline of the E levels in the last third of the 
luteal phase. This latter result seems to be at variance with the observation 
of Wilks et al. (11) who found a 100% incidence rate for this phenomenon in 
their study , versus 45% in our study. However, the differences between their 
study and our own must be very small since our E- pattern is practically iden­
tical with theirs. It is interesting to note that we found somewhat higher LH 
levels at the end of the luteal phase. We also found that the increasing FSH 
levels at the end of the luteal phase were more distinct and occurred at a 
higher frequency within animals. It is possible that these two observations 
are related to the observation that E levels do not decline in the late 
luteal phase. The ovary contains high concentrations of E at this stage of 
the cycle.(32). Furthermore, the possibility arises that the declining produc­
tion of estrogens by the corpus luteum is counteracted by the increasing E 
production by a new set of developing follicles that will eventually induce 
the next LH surge (33). Among investigators (1-11) the pattern of Ρ in the 
rhesus monkey is very much the same. In the follicular phase we found the 
first significant increased Ρ secretion at the day before the LH peak. Conse­
quently, Ρ levels are increased before LH reaches its peak value. Since the 
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LH secretion is also increased at the day before the LH peak, it is impossible 
to conclude that Ρ rises before LH. This pattern, Ρ rising at the same time 
or just after LH but before LH reaches its peak values, has also been found 
by others (5, 10, 35). Experiments in the early follicular phase suggest a 
facilitating effect of these Ρ increments on the E -induced gonadotropin re­
lease (14, 36). Ρ levels in the luteal phase are, just like E levels, lower 
than those observed in the human (26-29, 31). In our opinion,it is one of the 
most interesting findings in all but one monkey, and if the first day of the 
cycle is discarded even in all monkeys, that the highest Ρ concentrations in 
the follicular phase could be found at the day before or at the day of the LH 
peak. Therefore, the increasing Ρ levels in the late follicular phase may very 
well be used in the prediction of the LH surge. 
The levels of 20DHP are remarkably similar to those of P. This has been demon­
strated by a highly significant positive correlation between Ρ and 20DHP in 
all monkeys. To our knowledge, only incomplete data regarding the daily pat­
tern of 20DHP throughout the menstrual cycle of the rhesus monkey (12, 13). 
have been available so far. Our data are in agreement with and extend these 
data. In our study we found significantly increased 20DHP levels at the day 
of the LH peak Vs. the day before. However, in contrast with P, the increase 
of 20DHP is minor. In only two out of five monkeys we found the highest val­
ues of the follicular phase at the day before or at the day of the LH peak. 
That is why, in our opinion, Ρ is a far better predictor of the LH peak than 
20DHP. These data in the rhesus monkey confirm findings in the human female 
(19). As holds true for the other steroids in the rhesus monkey, 20DHP also 
runs at a lower level than in the human. 
The pattern of the 170HP concentrations in our study showed increasing levels 
in the second part of the follicular phase, followed by an abrupt rise within 
one day of the LH peak. Then a decline in the first part of the luteal phase 
was followed by a minor elevation in the middle third of the luteal phase. 
This minor elevation is at variance with the results of Bosu et al. who found 
in seven out of eight monkeys a secondary rise in the luteal phase comparable 
to that in the human (4, 37). This difference is suprising since we found pro­
foundly increased Ρ and 20DHP levels in our five monkeys. So this difference 
cannot be caused by a corpus luteum insufficiency in our five monkeys. The 
differences may be explained by the use of a different kind of analysis of 
the 170HP levels in their study and our own (competative binding assay vs. RIA). 
Our pattern of 170HP, however, closely resembles the pattern of 170HP in other 
macaques (38, 39). The predictive value of the 170HP concentrations for the LH 
27 
peak is probably not as reliable as the one of P, since the periovulatory 
170HP peak occurred in one out of five monkeys at the day after the LH peak. 
This tendency has also been observed, within a larger number of cycles inves­
tigated, in the human female (34). In addition to the statistical description 
of the time course of the six hormones in the menstrual cycle, we made an 
attempt to correlate the hormonal patterns with each other. This procedure 
was performed in order to gain more insight in the interactions between the 
hormones. This procedure, however, contains one difficulty, namely that when 
the concentration of one hormone is correlated with the concentration of an­
other, we do not take into account that the interactions between hormones are 
not only a function of their concentrations but also a function of the dura­
tion of their interactions (36, 40). Bearing this hazard in mind we found a 
significant negative correlation between E and FSH in the follicular phase. 
The "true" correlation between E and FSH is probably masked, since also a 
nonsteroidal product of the growing follicle, "inhibin", is also known to 
suppress FSH levels (41, 42). In the luteal phase we found no correlation be­
tween E and FSH. This result is at variance with observations in the human 
(43, 44). We did find ,however, in 90% of the monkeys a negative correlation 
between FSH and P. The same result was observed in the human (44). From these 
latter data it was concluded that a causal relation between FSH and Ρ is most 
unlikely since E and Ρ are positively related to each other and that a causal 
relation between E. and FSH is more likely. From our data in the rhesus monkey 
we may conclude the opposite, namely, that Ρ and FSH may be causally related 
since E. and Ρ are not. From our present study it can be concluded that the 
hormonal patterns in the rhesus monkey are quite similar to the patterns ob­
served in the human female with regard to the follicular phase and the peri­
ovulatory period. In the luteal phase, however, the steroid concentrations are 
at a lower level for Ρ and 20DHP and at a much lower level for E. and 170HP. 
The patterns of LH and FSH seemed to be relatively higher than in the human fe­
male, possibly as a consequence of these decreased steroid concentrations. 
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ABSTRACT 
The effects of progesterone (P) in midcycle concentrations on the estradiol 
(E )-induced gonadotropin release in the rhesus monkey were investigated by 
implanting Silastic capsules containing either crystalline E or P. All expe­
riments were begun on day 3 or 4 of the menstrual cycle and finished 96 h 
later. In the control cycles E capsules (E increments to approximately 250 
pg/ml) were implanted in all animals. In subsequent cycles E capsules were 
again implanted, but a Ρ capsule was added (P increment to approximately 1.2 
ng/ml) 0, 24, 32, and 46 h after the implantation of the E„ capsules (groups 
I, II III, and IV, respectively). The time of maximum gonadotropin release in 
the E plus Ρ cycles of all groups was advanced by approximately 12 h comp­
ared to their E- control cycles (P<0.05 to P<0.002). The mean maximum increase 
(Δ ) of LH and FSH of the study cycles in group I (simultaneous E„ plus Ρ 
max o r 2 r 
implants) was reduced to 70% of the E control means. When the time interval 
between the E and Ρ implantation was increased, the magnitude of the mean 
Δ of LH and FSH also increased. In group IV (P added 46 h after Ε„) the 
max e r 2 
mean Δ of the gonadotropins was 130% of the means in the E„ control cycles. 
max b ν 2 
These results point to a biphasic Ρ effect with time on the E -induced gonado­
tropin release. Similar effects were observed on the total amount of LH relea­
sed: in group I the study cycles showed an average decrease of 30%, and in 
group IV total LH released was approximately the same as in the control cycles 
Results for FSH were less marked. These data suggest that after adequate E 
priming (group IV), Ρ accelerates the release of the gonadotropins from the 
pituitary. As a result, maximum levels are reached earlier, and the peaks are 
shorter and higher than in the E control cycles. These results suggest a phy­
siological effect of the increasing Ρ levels at midcycle on the timing, magni­
tude, and duration of gonadotropin release.(Endocrinology 107:478, 1980) 
INTRODUCTION 
In the rhesus monkey it is possible to induce a premature release of LH and 
FSH in the follicular phase of the menstrual cycle with exogenous estradiol 
(E.) (1,2). From these and other studies it has been concluded that the rising 
estrogen levels at the end of the follicular phase are the primary trigger for 
the midcycle gonadotropin release (3). It has also been reported that at mid-
cycle there is a significant increase in the progesterone (P) levels of 
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approximately 1 ng/ml before LH and FSH reach their maximum values (4, 5). 
This slight rise in Ρ may be of physiological importance. In the human female 
(6-8) and in several other species (9-11), Ρ has been shown to exert a facil­
itating effect on gonadotropin release. Clifton et al. (12) reported an adva­
ncing effect of Ρ on gonadotropin release in the ovariectomized monkey. In 
the intact monkey, however, Ρ either blocked or did not alter estrogen-
induced gonadotropin release (12,13). A facilitating effect of Ρ in the rhe­
sus monkey could have been obscured by the design of previous experiments. In 
this study we investigated whether the effects of midcycle concentrations of 
Ρ on the E.-induced gonadotropin release are dependent on the time interval 
after the increase in E levels. 
MATERIALS AND METHODS 
Animals 
Female rhesus monkeys {Macaca mulatta) weighing 4.5-7.2 kg and having a 
history of regular ovulatory menstrual cycles of approximately 28 days' du­
ration (confirmed by daily LH, FSH, E , and Ρ determinations) were housed in 
individual cages under controlled temperature and light-dark cycles. The 
animals were maintained on monkey chow and fresh fruit. Each animal in the 
study had been trained to permit venipuncture without either physical or 
pharmacological restraint. 
Experimental •procedure 
In order to increase the E and Ρ levels, we implanted Silastic capsules 
sc, according to the method of Karsch et al. (2). These capsules contained 
either crystalline 17ß-estradiol (17ß-E ¡Diosynth) or crystalline Ρ (Diosynth, 
Oss, The Netherlands). The capsules were constructed as follows: 5 cm Silastic 
medical grade tubing (601-335;Dow-Corning Corp., Midland, MI) was sealed at 
one end with a 0.5-cm plug of Silastic medical grade elastomer (Dow-Corning) 
packed with 17β-Ε7, and then sealed at the other end in the same manner. Cap­
sules filled with progesterone were made in the same way but had a total 
length of 1.5 cm. Constant steroid release in vivo was obtained if the capsule 
had been preincubated in vitro for at least 24 h in 20 ml 1% bovine serum al­
bumin (BSA) saline solution. Thereafter the capsules were implanted between 
the scapulae via a small incision so that the rostral end of the capsule was 
approximately 2 cm caudal to the incision. The incision was closed with two 
sutures. In all cases two E„ capsules were implanted on the morning (0900-
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1000 h) of day 3 or 4 of the menstrual cycle and kept in place for 96 h (con­
trol cycle). In the subsequent study cycles, two E capsules were again im­
planted on day 3 or 4 of the menstrual cycle (between 0900 and 1000 h), but a 
1.5-cin Ρ capsule was implanted in addition 0, 24, 32, or 46 h after implant­
ation of the E- capsules {group I (n=7), group II (n=7), group III (n=9), and 
group IV (n=7), respectively}. Hormone levels during the study cycles in each 
group were compared with those during the E control cycles. In the study and 
control cycles, bloodsamples were obtained just before and 2, 8, 24, 32, 48, 
52, 56, 72, 80, and 96 h after the implantation of the E capsules. At 96 h 
all capsules were removed, and the final blood sample was obtained 2 h there­
after. In the study cycle of group IV, two additional bloodsamples were drawn 
at 46 and 50 h. Bloodsamples of 2 ml were obtained by femoral puncture (with­
out restraint) and were left to clot overnight at 4 C. Then they were centri-
fuged at 3000 rpm for 20 min. The serum was separated and stored at -20 С un­
til LH, FSH, E and Ρ concentrations were measured in all samples by RIA. 
FSH RIA 
FSH levels in serum samples were measured by a double antibody RIA using a 
modification of the heterologous system described by Boorman et al. (14). Rat-
FSH (NIAMDD-rat FSH-I-3) was radioiodinated with 1 2 5 I by a modification of 
the chloramine-T method of Greenwood et al., (15), purified by Sephadex G-100 
(Pharmacia, Piscataway, NJ) column chromatography, and used in combination 
with an antiserum to human FSH (antihuman FSH batch 4) in a final dilution of 
1:300.000. A partially purified rhesus pituitary gonadotropin preparation 
(LER 1909-2) was used as the standard. The results were expressed in terms of 
LER 1909-2. LER 1909-2 has a FSH biopotency of 0.042xNIH-FSH-S-l as measured 
in the Steelmann-Pohley assay (SPA) and a LH biopotency of 0.0031xNIH-LH-S-l 
as measured in an ovarian ascorbic acid depletion (OOAD) assay. The standard 
curves were composed from triplicate estimates at six points. The slope of 
the curve (15%-90% B/B ) was -1.30±0.05 (SD; n=16). The 90% B/B level was 65 
о о 
±7 ng (SD; n=16). The midpoint range (50% B/B ) was 354±46 ng (SD; n=16). At 
the 95% confidence level, 41+8 ng (n=16) could be differentiated from zero. 
All unknown samples were assayed in duplicate. Three hundred fifty microliters 
0.02 M phosphate buffered saline (PBS) plus 1% BSA, 50 μΐ sample or standard, 
and 50 μΐ antiserum were preincubated for 24 h at 4 C. Then 50 μΐ { l}rat 
FSH (55 pg/50 pl;SA, 80-100 pCi/pg) was added, and the incubation was compl­
eted 72 h later. For separating bound and free hormone, a sheep antirabbit 
immunoglobulin coupled to cellulose {double antibody solid phase (DASP, 
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Organon Teknika, Oss, The Netherlands)} was used. A pool of rhesus monkey se­
rum, containing 35.8±3.5 pg FSH/ml, assayed in dilutions in different assays 
(n=16), showed parallelism to the standard (range, 10%-75% B/B ) and gave 
intra- and interassay coefficients of variation of 10% and 12% respectively. 
LH RIA 
LH levels in serum samples were measured by a double antibody RIA using a 
modification of the heterologous system described by Niswender et al·. (16). 
Ovine LH (LER 1056-C2) was radioiodinated with 1 2 5 I , purified by Sephadex G-
100 column chromatography, and used in combination with an antiserum to ovine 
LH (antiovine LH GDN no. 15) in a final dilution of 1:300.000. The ovine LH 
preparation LER 1056-C2 shows parallelism to the partially purified rhesus pit­
uitary preparation LER 1909-2 and was used as the assay standard. The results 
were expressed in terms of LER 1056-C2, which has an LH biopotency of 1.73x 
NIH-FSH-S-1 as measured in an OAAD test and a FSH biopotency of 0.016xNIH-FSH 
-S-l as measured in a SPA. The standard curves were based on triplicate est­
imates of six points. The slope of the curve (15%-95%)B/B ) was -1.06±0.11 
(n=16). The 90% B/B level was 23±4.3 pg (n=16). The midrange (50% B/B ) was 
185±33 pg (n=16). At the 95% confidence level, 11±4 pg/(n=16) could be diff­
erentiated from zero. Dose-response curves of dilutions of rhesus monkey sam­
ples in different assays showed parallelism to the standard (50%-90% B/B ). 
All unknown samples were assayed in duplicate. Three hundred microliters PBS 
plus 1% BSA, 100 μΐ sample or standard, 50 yl antiserum, and 50 ul { 1 2 5I} 
ovine LH (70 pg/50 yl;SA, 70-90 pCi/pg) were incubated for 96 h at 4 С DASP 
was used to separate free and bound hormone. An ovine serum pool containing 
5.5±0.5 ng LH/ml (n=16), assayed in dilutions in different assays showed par­
allelism to the standard (range, 15%-95% B/B ) and gave intra- and interassay 
coefficients of variation of 12% and 13%, respectively. Dilutions of rhesus 
monkey serum, containing 2-3 ng/ml LH, showed similar results. 
E -P RIA 
E and Ρ levels were measured after Sephadex LH-20 (Pharmacia) column chro­
matography by a modification of the RIAs described by de Jong et at. (17, 18). 
Sephadex LH-20 was equilibrated with the eluting solvent mixture {toluene to 
methanol (9:1)} and packed into a 0.5-x30-cm column. Serum samples (500 μΐ) 
were extracted with diethyl ether (2x4 ml) after the addition of 1000 cpm of 
•{%}? and {3H}E in order to correct results for procedural losses. The resi­
dues of the diethyl ether extracts were taken up in 0.2 ml of the eluting 
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solvent and applied to the columns Ρ was eluted in the first 1.6-ml fraction. 
The next 0.5-m] fraction was discarded, and E was eluted in the final 2.8-ml 
fraction. The E„ and Ρ fractions were evaporated to dryness under nitrogen and 
dissolved in 450 μΐ distilled water and 1500 ui ethanol, resp. An aliquot of 
150 μΐ distilled water and 500 μΐ ethanol was taken in order to determine the 
recovery of the {ΊΗ}Ε (+ 70%) and the {3H}P (± 80%).respectively. 
For the E RIA, the residues of 75- and 150- μΐ aliquote were dissolved in 
50 μΐ 0.05 M PBS-0.5% gelatin buffer. Then 50 μΐ tracer (10,000 cpm {2,4,6,7-
3H} E,;SA, 100 Ci/mmol; Radiochemical Centre, Amersham, United Kingdom) and 
200 μΐ 1:30,000 rabbit antiserum to 17β-Ε -6-(0-carboxymethyl)-oxime-BSA were 
added to each sample and to the 178-E2 standards (0, 5, 10, 15, 30, 100, 150, 
and 200 pg in 50 μΐ 0.05 M PBS-0.5% gelatin buffer). After incubation for -16-
20 h at 4 C, the tubes were placed in an ice bath, and the free and bound 
steroids were separated by the addition of 1 ml cold dextran-coated charcoal 
in PBS buffer. After incubation for 10 min, the tubes were centrifuged at 
3000 rpm for 10 min at 0 С. The supernatant was decanted in vials, and 8 ml 
scintillation fluid (Aquasol, NEN Chemicals, Dreieich, West Germany) were 
added. Amounts of E were expressed in pg/ral serum after correction for water 
blanks (<5 pg per tube) and procedural losses. 
For the Ρ RIA, the residues of 75- and 150-μ1 aliquots were dissolved in 50 
μΐ 0.05 M PBS buffer, and then 50 yl tracer (10,000 cpm {1,2,6,7-3H}P; SA, 
100 Ci/mmol; Radiochemical Centre) and 200 μΐ 1:10,000 rabbit antiserum to 11 
a-hydroxy-progesterone-hemisuccinate-BSA were added to each sample and to the 
Ρ standards (0, 30, 50, 100, 200, 400, and 800 pg in 50 μΐ 0.05 м PBS The 
separation of free and bound Ρ was identical to the procedure described for 
the E„ RIA. Amounts of Ρ were expressed in ng/ml serum after correction for 
water blanks (<5 pg per tube) and procedural losses. Statistical evaluations 
of RIAs were performed using the programs of Rodbard and Lewald (19). 
Statistical methods used for comparison of control and experimental cycles 
within each group were the nonparametric two-tailed Mann-Whitney U-test and 
Student's t test. 
RESULTS 
Group I (E vs. E plus Ρ at 0 h) 
The effects of implantation of E only, and E plus Ρ are shown in Fig. 1 
and Tables 1 and 2. The implantation of two E capsules in the control cycles 
(n=7) on day 3 or 4 of the menstrual cycle increased the E levels to 245±47 
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Fig. 1. Serum LH, FSH, E , and Ρ concentrations in seven rhesus 
monkeys after implantation of two E capsules at 0 h (day 3 or 
4 of the menstrual cycle). Shaded areas. Results of these control 
cycles, shown as the interval between the meaniSE of seven obser­
vations. , Effects of the addition of a Ρ capsule simultan­
eously with the E. capsules at 0 h in the study cycles (mean±SE). 
At 96 h all capsules are removed. Bloodsamples have been drawn at 
the same time in the study and control cycles. 
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pg/ml (SD); Ρ levels remained low (0.41±0.11 ng/ml). LH and FSH reached their 
maximum values 67 h after implantation; the individual results are presented 
in Table 1. The mean maximum increase of LH and FSH above the levels observed 
at 0 and 98 h (Δ ) and the mean total amount of gonadotropins released (ex-
max 
pressed as the area under the LH and FSH curve) are given in Table 2. Coinci-
dently with the induced gonadotropin surge, an estrogen increase was measured, 
probably representing an ovarian response to the increasing gonadotropin 
levels (2,3). The addition of a Ρ capsule to the E capsules in the study cy­
cles of these seven monkeys (resulting hormone levels: E., 238+57 pg/ml; P, 
1.47+0.14 ng/ml) altered the dynamics of the estrogen-induced gonadotropin 
surge. LH and FSH now reached their maximum values approximately 50 h after 
implantation, 17 h earlier (P<0.02) than in the control cycles (Table 1). The 
Δ was decreased to 70% for LH and to 67% for FSH of the control cycle val-
max ' 
ues (Table 2). The same negative effect of Ρ in these study cycles could be 
observed on the total amount of gonadotropins released (Table 2). There was 
also an advancement of the gonadotropin-induced E peak concomitant with the 
shift of the gonadotropin peaks. 
Table 1. The time of maximum LH and FSH values in the E control cycles and 
in the study cycles with Ρ added simultaneously with Ε (Ε + Ρ) 
Monkey E control E + Ρ 
(no.) (h) (h) 
2 72 52 
138 56 52 
154 48 48 
J5 72 56 
2781 72 48 
J2 72 48 
139 80 48 
Mean 671 501 
This difference in time is significant (P<0.02, two-tailed Mann Whitney li­
test). 
Group II (E vs. E plus Ρ at 24 h) 
The effect of implantation of E only and Ρ 24 h after E„ is shown in Fig. 2 
and Tables 3 and 4. The hormone levels and timing of gonadotropin peaks in the 
(E only) cycles (n=7; E , 264±32 pg/ml) and P, 0.37±0.13 ng/ml) were compara-
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Fig. 2. -, Effect of implanting a Ρ caps­
ule 24 h after the E_ capsules in the study 
cycles (n=7) on LH, FSH, E and Ρ concentra­
tions. Shaded areas. Results of implanting E. 
only in the control cycles. See legend to Fig. 
1 for further details. 
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ble with those in the control cycles of group I. The addition of a Ρ capsule 
24 h after the £„ capsules in the study cycles of these animals (E-, 297±40 
pg/ml; Ρ after 24 h, 1.19±0.11 ng/ml) also advanced (as in group I) the time 
of maximum gonadotropin release after E implantation, but the advancement 
was now 13 h (F<0.01) Table 3). 
Table 2. The mean maximum LH and FSH increase from baseline (Δ ) and the 
max 
mean area under the LH and FSH curve {area in area units (AU)} in the E 
control and in the E» + Ρ study cycles. 
χ W O 1 
Л
тах
 L H
 'Ρ«/"11' 
Δ FSH (pg/ml) 
ІГШХ 
area LH (AU) 
area FSH (AU) 
E control 
45311062 
7.44±1.81 
127±45 
1760+404 
E 2 + Ρ 
319 + 74 
4.99 ±0.96 
89 ± 17 
1220 ±254 
E 2 + P 
E control 
70 
67 
70 
69 
Values are expressed as a percent. 
Values are the mean ± SE. 
The effect of Ρ on the Λ of LH was the same as in group I; in both groups 
an average decrease to 70% of their control cycle migth be observed (0.05<P< 
0.10, paired t test). The Δ of FSH, however, was now the same as in the 
max 
control cycles (Table 2). There was still a negative effect notable on the 
total amount of LH and FSH released (Table 4). Just as in group I, a shift of 
the E peak was measured: in four monkeys from 56 to 48 h and in two monkeys 
from 72 to 56 h. In one monkey no E peak was observed in either the control 
or study cycle. 
Group III (E vs. E plus Ρ at 32 h) 
The effect of implantation of E only and Ρ 32 h after E is shown in Fig. 
3 and Tables 5 and 6. The hormone levels and timing of gonadotropin peaks in 
the control (E only) cycles (n=9; E 265±34 pg/ml and P, 0.43±0.16 ng/ml) 
were comparable with those in the control cycles of groups I and II. The add­
ition of a Ρ capsule 32 h after the E capsules in the study cycles of these 
animals (E2, 279±56 pg/ml and Ρ after 32 h, 1.50±0.15 ng/ml) also advanced 
the time of the maximum gonadotropin release after E implantation, as in 
groups I and II. The advancement averaged 11 h (P<0.002, Table 5). The Δ^  
max 
of LH was now approximately the same as in the control cycles (Table 6). The 
Δ of FSH was increased to 139% of the control cycle values (Table 6). The 
max
 J 
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Fig. 3. — , Effect of implanting a Ρ capsule 32 h after 
the E capsules in the study cycles (n=9) on LH, FSH, E , 
and Ρ concentrations. Shaded areas. Results of implanting 
E alone in the control cycles. See legend to Fig. 1 for 
further details. In the study cycles FSH is higher than in 
the control cycles at 48 and 52 h (**P<0.01, *P<0.05
> 
paired student t test). 
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Table 3. The time of maximum LH and FSH values in the E control cycles and 
in the study cycles with Ρ added 24 h after E (E + P->-24) 
Monkey 
(no.) 
E control 
(h) 
E + P+24 
(h) 
2 
138 
2836 
2769 
J5 
139 
2843 
Mean 
72 
56 
56 
56 
72 
72 
48 
62 1 
48 
48 
48 
48 
52 
48 
48 
491 
^his difference in time is significant (P<0.01, two-tailed Mann-Whitney li­
test). 
FSH levels at 48 and 52 h were significantly higher than the values observed 
in the control cycles (Fig. 3), pointing to an accelerated release of FSH 
from the pituitary. The effects of Ρ on the amount of gonadotropins released 
are shown in Table 6. The coincident shift of the E. peak with the gonadotro­
pin peak can be seen clearly in Fig. 3. 
Table 4. The mean maximum LH and FSH increase from baseline (Δ ) and the 
max 
mean area under the LH and FSH curve {area in area units (AU) } in the E. con­
trol cycles and in the study cycles with Ρ added 24 h after E 
Δ 
max 
Δ 
max 
area 
area 
LH (pg/ml) 
FSH (pg/ml) 
LH (AU) 
FSH (AU) 
E. control 
472±155э 
7.11±1.42 
88+40 
1554+342 
Е 2 + Р-+24
1 
321±72 
7.18±2.83 
49±12 
1157±437 
І2-
Е2 
+ P-Î-24 
control 
68 
101 
55 
74 
χ lOO2 
1
Е 2 + Ρ->·24, Study cycles with Ρ added 24 h after E . 
Values are expressed as a percent. 
Values are the mean ± SE. 
Group IV (E us. E, plus Ρ at 46 h) 
The effect of implantation of 
4 and in the Tables 7 and 8. The hormone levels and timing of gonadotropin 
E only and Ρ 46 h after E. is shown in Fig. 
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Table 5. The time of maximum LH and FSH values in the E control cycles and 
in the study cycles with Ρ added 32 h after E (E + P-*32 h) 
Monkey E control Ε + Ρ-»·32 
(no.) (h) (h) 
2 72 52 
138 56 48 
2836 56 48 
2769 56 48 
J5 72 48 
139 72 48 
2843 48 48 
F49 56 48 
F4 56 52 
Mean 601 49 1 
^his difference in time is significant (P<0.002, two-tailed Mann-Whitney li­
test). 
Table 6. The mean maximum LH and FSH increase from baseline (Δ ) and the 
max 
mean area under the LH and FSH curve {area in area units (AU)} in the E con­
trol cycles and in the study cycles with Ρ added 32 h after E-
E 2 control E 2 + P+32
1
 E
:
 + P+32
 χ l o o 2 
E control 
Δ LH (pg/ml) 570±1613 610±99 108 
_max 
Δ FSH (yg/ml) 7.55±1.13 10.50±2.91 139 
max 
area LH (AU) 148±51 99±21 66 
area FSH (AU) 1604±271 1328±304 83 
lE + P-K32, Study cycles with Ρ added 32 h after E . 
Values are expressed as a percent. 
3Values are the mean ± SE. 
peaks in the control (E only) cycles (n=7; E_, 239±40 pg/ml and P, 0.45±0.14 
ng/ml) were comparable with those of the control cycles in the previous groups. 
As in the previous groups, the addition of a Ρ capsule 46 h after the E_ cap­
sules in the study cycles of these animals (E., 266±51 pg/ml and Ρ after 46 h, 
1.26+0.21 ng/ml)advanced the time of the maximum gonadotropin release after 
the implantation, now by 13 h (P<0.05, Table 7). The effect of Ρ on the Δ 
45 
of FSH was the same as in group III; in both groups an average increase to 
130% of their control cycle values could be observed (0.05<P<0.10, paired t 
test). Ρ effected the Δ of LH in this group in the same way; an average 
max o r j 
increase to 130% was observed (P<0.05). 
Table 7. The time of the maximum LH and FSH values in the E control cycles 
and in the study cycles with Ρ added 46 h after E (E + P->-46) 
Monkey E control E. + P-»-46 
(no.) (h) (h) 
2 72 52 
138 56 52 
J12 72 56 
154 48 48 
J5 72 52 
139 72 52 
162 72 56 
Mean 661 531 
^his difference in time is significant (P<0.05l two-tailed Mann-Whitney li­
test). 
Table 8. The mean maximum LH and FSH increase from baseline (Δ ) and the 
max 
mean area under the LH and FSH curve {area in area units (AU)} in the E, con­
trol cycles and in the study cycles with Ρ added 46 h after E . 
χ 100 2 
Δ 
max 
Δ 
max 
area 
area 
LH (pg/ml) 
FSH (pg/ml) 
LH (AU) 
FSH (AU) 
E control 
548±125 3 
7.43+1.76 
143151 
1849+389 
E 2 + P+46
 1 
702+50 
9.3613.27 
131+33 
13661268 
E
n
 + P-+46 
E control 
128 
126 
92 
74 
1E + P+46, Study cycles with Ρ added 46 h after E . 
Values are expressed as a percent. 
^Values are the mean + SE. 
The values of LH and FSH at 52 and 56 h in the study cycles were also signif­
icantly higher than in the control cycles (Fig. 4), showing an accelerated 
release of both gonadotropins from the pituitary. The effect of Ρ on the total 
amount of gonadotropins released can be seen in Table 8. When all P-treated 
46 
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Fig. 4. -, Effect of implanting a Ρ capsule 46 h after the 
E capsules in the study cycles (n=7) on LH, FSH, E„, and Ρ 
concentrations. Shaded areas. Results of implanting E alone 
in the control cycles. In the study cycles two additional 
blood samples have been drawn at 46 and 50 h. See legend to 
Fig. 1 for further details. In the study cycles LH and FSH are 
higher than in the control cycles (**P<0.05, * 0.10<P<0.05, 
paired t test) at 52 and 56 h respectively. 
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cycles in groups I to IV were compared with their control cycles, the average 
amount of gonadotropins released seemed to be decreased (0.05<P<0.10, t test). 
The coincident shift of the E peak with the gonadotropin peak can also be 
observed in this group. 
DISCUSSION 
Several authors have shown that high Ρ levels (3-8 ng/ml) were able to 
block spontaneous and E -induced gonadotropin release in the intact rhesus 
monkey (12,13,20). In those experiments, luteal levels of Ρ were used to in­
vestigate the effects of Ρ on gonadotropin release. However, at midcycle the 
concentration of Ρ is approximately 1 ng/ml (4,5), and thus, a facilitory 
role for preovulatory concentrations of Ρ in gonadotropin release could have 
been obscured in previous experiments by the use of too high Ρ concentrations. 
Dierschke et al. (13) investigated the effects of preovulatory concentra­
tions of P. They demonstrated that the administration of Ρ in final concen­
trations of 1 ng/ml 48 h before an E. increment either blocked or did not 
alter the dynamics of the E -induced LH and FSH surges. This time sequence, 
however, does not conform to the midcycle hormonal events, in which the rise 
of £_ precedes the rise of Ρ (4,5). Thus, facilitating effects of Ρ in pre­
ovulatory concentrations on gonadotropin release may have been obscured in 
these experiments by the use of an inappropiate time sequence. We therefore 
investigated whether a facilitory effect of Ρ on the E -induced gonadotropin 
release could have been obscured 1) by using too high Ρ levels and 2) by neg­
lecting the time relationship between the hormones seen at midcycle. From 
the results shown in Tables 1-8 it can be concluded that the time relationship 
between an E increment and a Ρ increment is of great importance in determing 
the magnitude of the LH and FSH surges. The Д LH and FSH increased from 30 
β 0
 max 
% below (group I, E. plus P) to 30% above control cycle values (group IV, E 
plus P->46) . In groups II and III the FSH/LH peak ratio was greater in the 
study cycles than in their control cycles. This suggests that FSH is less 
sensitive than LH to the time-dependent negative action of Ρ on peak serum 
values. These observations point to the importance of the time interval be­
tween E. and Ρ increments for both the magnitude of the LH and FSH surges and 
the ratio of the LH and FSH peak values. Since it is generally believed that 
there is only one hypothalamic releasing factor involved (GnRH) for both LH 
and FSH, the change of the LH/FSH ratio might represent an action of Ρ at the 
48 
pituitary level. Alternatively, the differing ratios of Δ FSH/Δ LH might r J
 * max max
 0 
be explained as reflecting the sequence of increase in production and storage 
of LH and FSH. Although the magnitude and the ratio of LH and FSH surges cha­
nged in the study cycles, the time after which gonadotropin surges reached 
their maximum values was very constant and occurred 48 or 52 h after E impl­
antation in 90% of the study cycles. Thus, in all groups peak values of LH 
and FSH were observed earlier in the study cycles than in the control cycles. 
The magnitude of the gonadotropin peaks was dependent on the duration of the 
E_ priming before the administration of P. When the system was adequately 
primed, from a temporal viewpoint, it responded quickly with an accelerated 
LH and FSH release to the Ρ increment. These effects can be noted in group IV 
to which, after 46 h priming, Ρ was added to the system and LH and FSH relea­
se was accelerated. Thus at 52 and 56 h levels were significantly higher (Fig. 
4) than with E only. Peaks were advanced and occurred an average of 6 h after 
Ρ administration. This time interval of 6 h between the first Ρ increment and 
the gonadotropin peak is in accordance with the time relationshop at midcycle 
as reported by Weick et al. (4). After this acceleration of release, gonado­
tropin levels declined steeply suggesting a terminating effect of Ρ on the 
gonadotropin surges. This was notable in all groups (Figs. 1-4). This termi­
nating effect may also explain the decreased amount of gonadotropins released 
in all groups. An interesting observation is that, concomitant with the shift 
of the gonadotropin peaks, the gonadotropin-induced E- peak was usually also 
advanced. Thus, not only can peak levels of LH and FSH be advanced with P, but 
also threshold levels of the gonadotropins that can induce biological effects. 
The effects of Ρ (acceleration and termination) result in shorter duration of 
the gonadotropin surges and advanced peak levels of these surges. These data 
support findings in the human (6-8) and in other species (9, 10, 11, 21) and 
suggest a physiological role for Ρ in the midcycle gonadotropin release. This 
point would have been established more clearly if midcycle gonadotropin pro­
files during spontaneous cycles in these monkeys, obtained with the same sam­
pling frequency as in the experimental cycles, were available for comparison. 
It is apparent, however, that the shape of the gonadotropin surges in the E 
plus Ρ cycles is different from that in the E only cycles. Especially in 
group IV, when steroid increments resemble the periovulatory profiles obtained 
with a high sampling frequency (4), the induced gonadotropin surges also re­
semble the spontaneous midcycle profiles (4). At midcycle the following seque­
nce of events may be suggested: the rising E levels at the end of the folli-
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cular phase serve to initiate the LH and FSH release; the increasing LH levels 
then stimulate the production of Ρ by the ovaries (22-24); the resulting in­
creasing Ρ levels then accelerate the release of the gonadotropins from the 
pituitary, and thus, threshold levels of LH, which initiate events leading to 
ovulation, are obtained a few hours after the rise of the Ρ levels. Addition­
ally, the increasing Ρ levels contribute to the termination of the LH and FSH 
surges. In this way the duration of the gonadotropin surge will not be longer 
than required for the induction of ovulation. In a study by Peters et al. 
(25), exposure of the ovary in 22-day-old mice to exogenous gonadotropins re­
stored large atretic follicles, and this may explain the excessive number of 
eggs ovulating in response to the gonadotropin injection. It might be conclu­
ded from this data together with our experiments that Ρ may play a role in 
the mechanisms controlling monoovulation in the primate by decreasing the du­
ration of gonadotropin release at midcycle. 
REFERENCES 
1. Yamaji T, Dierschke DJ, Hotchkiss J, Bhattacharya AN, Surve AH, Knobil E 
1971 Estrogen induction of LH release in the rhesus monkey. Endocrinology 
89:1034 
2. Karsch FJ, Weick RF, Butler WR, Dierschke DJ, Krey LC, Weiss G, Hotchkiss 
J, Yamaji T, Knobil E 1973 Induced LH surges in the rhesus monkey: strength 
-duration characteristics of the estrogen stimulus. Endocrinology 92:1740 
3. Knobil E 1974 On the control of gonadotropin secretion in the rhesus monkey 
Recent Prog Horm Res 30:1 
4. Weick RF, Dierschke DJ, Karsch FJ, Butler WR, Hotchkiss J,Knobil E I 9 7 3 
Periovulatory time courses of circulating gonadotropic and ovarian hormones 
in the rhesus monkey. Endocrinology 93:1140 
5. Pauerstein CJ, Eddy CA, Croxatto, HD, Hess R, Siler-Khodr TM, Croxatto HB 
1978 Temporal relationship of estrogen, progesterone and luteinizing hor­
mone levels to ovulation in woman and infrahuman primates. Am J Obstet Gyn­
ecol 130:186 
6. Chang RJ, Jaffe RB 1978 Progesterone effects on gonadotropin release in 
women pretreated with estradiol. J Clin Endocrinol Metab 47:119 
7. Leyendecker G, Wildt L, Gips Η, Nocke W, Plotz EJ 1976 Experimental studies 
on the positive feedback effect of progesterone 17oi-hydroxyprogesterone and 
20a-dihydroprogesterone on the pituitary release of LH and FSH in the human 
female. Arch Gynecol 221:29 
50 
8 Odell WD, Swerdloff RS 1968 Progesterone-induced luteinizing and follicle 
stimulating hormone surge in postmenopausal women: a stimulated ovulatory 
peak Proc Natl Acad bei USA 61.529 
9. Hilliard J, Penardi R, Sawyer CH 1967 A functional role for 20a-hydroxy-
pregn-4-en-3-one in the rabbit Endocrinology 80 901 
10. Brown-Grant K, Naftolin F 1972 Facilitation of luteinizing hormone secret­
ion in the female rat by progesterone J Endocrinol 53.37 
11 Joslyn WD, Wallen К, Goy RW 1976 Advancement of ovulation m the guinea 
pig with exogenous progesterone and related effects on length of the oes­
trus cycle and life span of the corpus luteum J Endocrinol 70*275 
12. Clifton DK, Steiner RA, Resko JA, Spies HG 1975 Estrogen-induced gonado­
tropin release in ovarlectomized rhesus monkeys and its advancement by 
progesterone Biol Reprod 13·190 
13 Dierschke DJ, Yamaji T, Karsch FJ, Weick RF, Weiss G, Knobil E 1973 Block­
ade by progesterone of estrogen-induced LH and FSH release in the rhesus 
monkey Endocrinology 92 "1496 
14 Boorman GA, Niswender GD, Gay VL, Reichert Jr LE, Midgley Jr AR 1973 Radio­
immunoassay for follicle-stimulating hormone m the rhesus monkey using an 
anti-human FSH serum and rat FSH 1 3 1I Endocrinology 92:618 
15. Greenwood FC, Hunter WM, Glover JS 1963 The preparation of 131I-labelled 
human growth hormone of high specific radioactivity Biochem J 89:114 
16. Niswender GD, Monroe SE, Peckham WD, Midgley Jr AR, Knobil E, Reichert Jr 
LE 1971 Radioimmunoassay for rhesus monkey luteinizing hormone (LH) with 
anti-ovine LH serum and ovine LH- 1 3 1I. Endocrinology 88 1327 
17 de Jong FH, Hey AH, van der Molen HJ 1973 Effect of gonadotropins on the 
secretion of oestradiol-17ß and testosterone by the rat testis. J Endo-
crinol 57:277 
18 de Jong FH, Baird DT, van der Molen HJ 1974 Ovarian secretion rates of 
oestrogens, androgens and progesterone in normal women and in women with 
persistent ovarian follicles Acta Endocrinol (Copenh) 77:575 
19. Rodbard D, Lewald JE 1970 Computer analysis of radioligand assay and radio-
immunoassay data. Acta Endocrinol {Suppl}(Copenh) 147:79 
20. Spies HG, Niswender GD 1972 Effect of progesterone and estradiol on LH re-
lease in rhesus monkeys Endocrinology 90:257 
21. Freeman MC, Dupke КС, Croteau CM,1976 Extinction of the estrogen-induced 
daily signal for LH release in the rat: a role for the proestrus surge of 
progesterone. Endocrinology 99:223 
22. Hayward JN, Hilliard J, Sawyer CH 1963 Preovulatory and postovulatory 
51 
progestins in monkey ovary and ovarian vein blood. Proc Soc Exp Biol Med 
113:256 
23. Resko JA, Koering MJ, Goy RW, Phoenix CH 1975 Preovulatory progestins: ob-
servations on their source in rhesus monkeys. J Clin Endocrinol Metab 41: 
120 
24. Ross GT 1976 Preovulatory determinants of human corpus luteum function. 
Eur J Obstet Gynaecol Reprod Biol 6:147 
25. Peters H, Byskov AG, Himmelstein-Braw R, Faber M 1975 Follicular growth: 
the basic event in the mouse and human ovary. J Reprod Fértil 45:559 
52 
CHAPTER III 
A Strength and Duration Characteristic of the 
Facilitory and Inhibitory Effects of Progesterone 
on the Estrogen-Induced Gonadotropin Surges in 
the Female Rhesus Monkey. 
Helmond FA, Simons PA, Hein PR 
University Clinic for Obstetrics and Gynecology, 
Catholic University, Nijmegen, The Netherlands 
Present address: Department of Animal Physiology, 
Agricultural University, Wageningen, The Netherlands 
Endocrinology 108:in press (1981) 
53 
ABSTRACT 
The dose dependent effects of progesterone (P) on the estradiol (E„)-induced 
gonadotropin release were investigated in the early follicular phase of female 
rhesus monkeys by implanting (sc) Silastic capsules containing either crystal­
line E or P. In group 1 (n=7), E. alone (250 pg/ml) and E in combination 
with Ρ (1.5, 3, and 5 ng/ml) was administered in four subsequent experiments. 
The lowest Ρ dosage (1.5 ng/ml) advanced the time of the maximum gonadotropin 
release, but the magnitude seemed to be decreased when compared to the expe­
riment with E alone. The highest Ρ dosages (3 and 5 ng/ml) blocked the pre­
viously observed, E -induced, gonadotropin surges. In group 2 (n=7), E alone 
(250 pg/ml) and E in combination with Ρ (1.5, 5, and 20 ng/ml), P, added 46 h 
after E , was administered in four subsequent experiments. In all experiments 
Ρ advanced and increased the gonadotropin peaks. The FSH surges could be in­
creased even further in the experiments with the two highest Ρ dosages (5 and 
20 ng/ml). After this period of facilitated gonadotropin secretion we obser­
ved lower gonadotropin levels than those in the E- alone control experiment. 
This effect became more apparent by increasing the Ρ dosage. These results 
point to a biphasic Ρ effect across time and dosage on the release of gonado­
tropins . 
INTRODUCTION 
In the human as well as in the rhesus monkey it is a well known fact that, 
at midcycle, progesterone (P) starts to rise to levels of approximately 1 ng/ 
ml before luteinizing hormone (LH) and follicle-stimulating hormone (FSH) 
reach their maximum values (1-4). In a previous article we have demonstrated 
an advancing effect of these Ρ increments on the estradiol (E,.)" induced gona­
dotropin release(5). The magnitude of the advanced gonadotropin peaks was de­
pendent on the duration of the E priming before the administration of P. Af­
ter a 46 h E priming Ρ advanced and increased the gonadotropin release. In 
all these experiments Ρ levels were increased to 1-1.5 ng/ml. The effects of 
high levels of Ρ (3 ng/ml or higher) are known to completely block the spon­
taneous and E - induced gonadotropin peaks in the intact rhesus monkey (6-8). 
In all these studies high increments of Ρ were administered relatively long 
before the expected gonadotropin surge. In the present study we have inves­
tigated whether the effects of high increments of Ρ are different when admini­
stered at the same time with E or 46 h thereafter. 
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MATERIALS AND METHODS 
Female rhesus monkeys (Macaca mulatta) having a history of regular menstru­
al cycles were used in this study. Increments of E and Ρ were made by im­
planting sc Silastic capsules containing either crystalline 176-E or P. 
In a previous article we described the construction of the Silastic capsules, 
the implantation procedure,the blood sampling procedure, and the RIA systems 
used for the determination of LH, FSH, E and Ρ (5). The standards used for 
LH and FSH were LEK 1056-C2 and LER 1909-2 respectively. Two groups of seven 
monkeys each were studied. In group 1,P capsules were implanted at the same time 
with the E capsules and in group 2 , 46 h after the E capsules. In group 1, 
all seven monkeys underwent in four subsequent cycles the following treat­
ments: in experiment one, two E capsules of 4 cm length were implanted be­
tween 0900 and 1000 h on day 3 or 4 of the menstrual cycle; in experiment 
two, a 1-cm Ρ capsule was implanted at the same time with the E capsules; 
in experiment three, a 2-cm Ρ capsule, and in experiment four a 4-cm Ρ cap­
sule was implanted. In group 2, also four experiments were performed in seven 
monkeys in four subsequent cycles. In experiment one, two Έ, capsules of 4 cm 
length were implanted between 0900 and 1000 h on day 3 or 4 of the menstrual 
cycle. In experiment two, a 1-cm Ρ capsule was added 46 h after the E cap­
sules. In experiment thi.ee, a 4-cm Ρ capsule was added 46 h after the E cap­
sules, and in experiment four, four Ρ capsules of 4 cm length were implanted 
46 h after the E capsules. 
These steroid treatments in the early follicular phase prolonged the length 
of the follicular phase with approximately 12 days. The subsequent luteal 
phase was normal in length and in hormone concentrations (9). Thus, the last 
28 days of the experimental cycles showed hormone concentrations (LH, FSH, E. 
and Ρ) indistinguishable from normal values. Similar findings have been made 
in the human (10). From these results we concluded that it is possible to run 
experiments in close proximity to one another. In general, however, the ani­
mals were allowed to have a normal untreated cycle in between experiments. 
In the experiments blood samples were drawn just before and 2, 8, 24, 32, 
48, 52, 72, 80, and 96 h after the implantation of the E capsules. At 96 h 
after the implantation all capsules were removed, and the final blood sample 
was obtained 4 h thereafter. Two additional blood samples were drawn at 46 h 
and 50 h in group 2 in experiment 2, 3, and 4. 
Statistical evaluations of radioimmunoassays were performed using the pro-" 
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grams of Rodbard and Lewald (11). Statistical methods used for comparison of 
control and experimental cycles within each group were the nonparametric two-
tailed Mann-Whitney U test and Student's t test. Lineair regression analysis 
has been used to correlate FSH levels with time. 
RESULTS 
Group 1 (E vs. E + Ρ) (Fig. 1) 
GROUP 1 (η = 7) 
Exp 2 
2E,.1cmP 2E,.1cmP 
ЕхрЭ 
2E2»2cmP 2E,.2cmP 
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Fig. 1. Serum LH, FSH, E. and Ρ concentrations in the same 
seven monkeys after implantation of two E capsules at 0 h 
(day 3 or 4 of the menstrual cycle) in experiment 1 and 
after implantation of Ρ capsules of various length simul­
taneously with the E capsules in experiment 2,3, and 4. 
At 96 h all capsules are removed. Blood samples have been 
drawn at the same time in the control and study cycles. 
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Experiment 1 : In this experiment the seven monkeys received only E cap­
sules. This resulted in E increments to 274±53 (SD) pg/ml. Ρ levels remained 
low (0.4+0.2 ng/ml). LH and FSH reached their maximum values on the average 
67 h after implantation; the individual results are presented in Table 1. The 
mean maximum increase of LH and FSH above the levels observed at 0 and 100 h 
( Δ ) was 635±144 (SEM) pg/ml and 5.8±1.1 pg/ml respectively. The total a-
mount of gonadotropins released (expressed as the area under the LH and FSH 
curve) was 177+56 (SEM) Area Units (AU) and 1399±276 AU for LH and FSH respec­
tively. During the course of the gonadotropin surge a rise of E could be 
observed (Fig. 1). 
Table 1. The time of the maximum LH and FSH values in the E control cycles 
and in the study cycles with Ρ added simultaneously with Ε ( Ε + Ρ ) 
Monkey 
(no.) 
2769 
F4 
154 
138 
J5 
2781 
139 
Mean 
E2 control 
(h) 
56 
56 
72 
56 
72 
72 
72 
651 
E2 + 1-
(h) 
48 
48 
48 
52 
56 
48 
48 
501 
cm Ρ E2 + 2-cm Ρ 
(h) 
-
-
-
-
-
-
-
E + 4-cm Ρ 
(h) 
-
-
-
-
-
-
-
This difference in time is significant (P<0.01, two-tailed Mann-Whitney U-
test). 
Experiment 2 : In this experiment the same seven monkeys received, in ad­
dition to the E capsules, a Ρ capsule of 1 cm length. This resulted in F. 
increments to 247±66 pg/ml and Ρ increments to 1.4±0.1 ng/ml. The increased 
Ρ levels advanced on the average the time of the maximum gonadotropin levels 
by 17 h to 50 h after Ε + Ρ implantation (see Table 1 for individual re­
sults). Concomitant with the shift of the gonadotropin peak, an advancement 
of the gonadotropin induced E, peak could be observed (Fig. 1). Δ FSH de­
creased to 4.2+0.7 Ug/ml (P<0.01); Δ LH decreased over 50% in five monkeys; 
max 
in one monkey Δ LH did not change and in the remaining monkey a slight in-
max 
crease of the Δ LH was observed. On average Δ LH declined to 364±63 pg/ 
max max 
ml. This result is not significant (0.05<P<0.10). The total amount of gonado­
tropins released, decreased over 50% in five out of seven monkeys. The re-
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maining two sligthly increased their release. On the average LH was decreased to 
95±14 AU and FSH to 1066±231 AU. This result is not significant (О.05<Р<0.10). 
Experiment 3: The addition of a 2-cm Ρ capsule to the E capsules in the seven 
monkeys resulted in Ρ increments to 2.8+0.2 ng/ml. The E levels were during 
this experiment 243+22 pg/ml. The latter Ρ increments blocked the previously 
observed gonadotropin peaks completely. During the experiment FSH, but not LH, 
gradually declined to 50% of the initial basal values. This was demonstrated 
with a lineair regression analysis (r= -0.36, Γ<0.002). 
Experiment 4: The addition of a 4-cm Ρ capsule to the E capsules in the seven 
monkeys resulted in Ρ increments to 5.3+0.4 ng/ml. The E levels were 234+54 
pg/ml during the experiment. As in the previous experiment these Ρ increments 
also blocked the previously observed gonadotropin surges. These higher Ρ in­
crements did not enhance the negative feedback of the E and Ρ concentrations 
as observed in the previous experiment. Again FSH, but not LH, gradually de­
clined to 50% of the initial basal values (r= -0.42, P<0.001). 
Group 2 (K vs E + Ρ at 46 h) (Fig. 1) 
Experiment 1: As in the previous group the effects of E„ alone were estab­
lished in seven monkeys. The implantation of the E capsules resulted in E 
increments to 285±53 pg/ml. These E increments evoked LH and FSH peaks on the 
average 70 h after implantation. The individual results are presented in Table 
2. The ~K of LH and FSH were resp. 529±120 pg/ml and 4.710.9 ye/ml. The total 
max 
amount of LH and FSH released was 107±42 AU and 1196121 AU respectively. 
During the course of the gonadotropin surge a rise of E could be observed 
(Fig. 2). The basal LH values of monkey F4 in group 1 were higher than those 
of the other monkeys in group 1 and 2. As a consequence the mean LH concentra­
tions of all sample points of experiment 1 in group 1 seemed to be higher than 
in group 2. If the LH results are corrected, by subtraction of the basal val­
ues , the LH curves of the first experiment in group 1 and 2 are practically 
identical. This is also reflected in a nonsignificant difference between the 
Δ LH in these experiments (P>0.20, t test). Owing to the high uncorrected LH 
max 
concentration in the 56 h sample of monkey F4, the mean LH peak in the first 
experiment of group 1, seemed to be at 56 h, despite the fact that the majority 
of the monkeys showed their highest LH concentrations in the 72 h sample (see. 
Table 1). Also in this experiment of group 2 the majority of monkeys showed 
their highest LH concentration in the 72 h sample (see Table 2). As a conse­
quence, the timing of the gonadotropin peak was not significantly different 
between these experiments (i'>0.20, Mann Whitney U-test). 
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Fig. 2 Serum LH, FSH, E_ and Ρ concentrations in the same 
seven monkeys after implantation of the two E capsules at 
0 h in experiment 1 and after implantation of Ρ capsules 
of various length 46 h after the E- capsules in experiment 
2, 3, and 4. In the study cycles two additional blood 
samples have been drawn at 46 and 50 h. Note the broken 
line and its corresponding inner scale used for graphing 
the Ρ concentrations in exp 4. See legend to Fig. 1 for 
further details. 
Experiment 2: In this experiment, in the same seven monkeys, a 1-cm Ρ capsule 
was implanted 46 h after the E capsules. E. levels during the experiment were 
272±57 pg/ml and Ρ levels after 46 h were increased to 1.2±0.3 ng/ml. The in­
creased Ρ levels in this experiment accelerated immediately the release of LH 
and FSH. This resulted in significantly advanced peak levels (see Table 2 for 
individual results) and significantly increased LH (P<0.005) and FSH (P<0.01) 
levels at 52 h when compared to experiment 1. A shift of the E peak simultan­
eously with the gonadotropin peak could be observed. In this experiment the 
levels at 52 h were higher than those at 72 h in experiment 1 for LH (P<0.05) 
but not for FSH (P>0.10). The total amount of LH and FSH released, remained 
the same and was 137±34 AU and 976+150 AU respectively. 
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Table 2. The time of the maximum LH and FSH values in the E control cycles 
and in the study cycles with Ρ added 46 h after E (E + P->46). 
Monkey 
(no.) 
J2 
2769 
154 
J5 
139 
162 
J12 
Mean 
E control 
(h) 
72 
56 
72 
72 
72 
72 
72 
701 
E + 1-cm 
(h) 
52 
52 
48 
52 
52 
56 
56 
532 
P->46 E + 4-cm 
(h) 
52 
56 
50 
52 
52 
52 
52 
522 
P-*46 E + 4x4-ci 
(h) 
52 
52 
52 
52 
52 
52 
52 
522 
1
'
2This difference in time is significant (P<0.002, two-tailed Mann Whitney 
U-test) 
Experiment 3: The addition of a 4-cm Ρ capsule 46 h after the E capsules re­
sulted in Ρ increments to 5.3±0.8 ng/ml. The E. levels were 288±52 pg/ml du­
ring the experiment. In contrast to experiment 4 of group 1 the gonadotropin peak 
could not be blocked with these luteal levels of Ρ in this experiment. The lu­
teal levels of Ρ now accelerated the release of LH and FSH. This resulted in 
significantly increased LH (P<0.025) and FSH (F<0.025) levels at 52 h and sig­
nificantly advanced peak levels (see Table 2 for individual results) when com­
pared to experiment 1. A shift of the E peak simultaneously with the gonado­
tropin peak could be observed. In this experiment LH (P<0.01) and FSH (P<0.01) 
levels at 52 h were higher than the levels at 72 h in experiment 1. In compa­
rison to experiment 2 (with the 1 cm Ρ capsule), six out of seven monkeys in­
creased the Δ of FSH and the remaining monkey decreased the Δ of FSH. 
max _ о j
 m a x 
On the average the Δ of FSH was 7.5±1.5 pg/ml in this experiment compared 
max 
to 5.5±0.7 yg/ml in experiment 2 (for significance see experiment 4). At 72 h 
LH (P<0.05) but not FSH (P<0.10) levels were lower than in experiment 2. The 
total amount of LH and FSH released was 113±21 AU and 1239±316 AU respectively. 
These values were comparable with those observed in experiment 1 and 2. 
Experiment 4: The addition of four 4-cm Ρ capsules 46 h after the E capsulesi 
resulted in Ρ increments exceeding the normal luteal range. After 46 h Ρ levels 
were 18.9±4.2 ng/ml. E levels were 243±54 pg/ml during the experiment. Even 
these supraphysiological levels of Ρ accelerated the release of LH and FSH. 
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This resulted in significantly advanced peak levels (see Table 2 for individu­
al results) and significantly increased LH (P<0.025) and FSH (p<0.05) levels 
at 52 h when compared to experiment 1. A shift of the E peak simultaneously 
with the gonadotropin peak could be observed. In this experiment the LH (0.05 
<P<0.10) and FSH (P<0.05) levels at 52 h seemed to be higher than those at 72 
h in experiment 1. In comparison to experiment 2, five out of seven monkeys 
increased the Д of FSH and the remaining two decreased the Δ of FSH 
max max 
slightly. On the average the Δ of FSH was 8.4±2.1 pg/ml. When the FSH re­
sults of experiment 3 and 4 were simultaneously compared with those in experi­
ment 2, then FSH was stimulated further with the high Ρ increments (P<0.01). 
At 72 h both LH and FSH were lower in comparison with experiment 2 (P<0.005 
and P<0.01 respectively). Also at 56 h LH (F<0.001) but not FSH (p>0.10) lev­
els were lower than when compared to experiment 2. When compared to experiment 
3, LH (P<0.001) and FSH (P<0.025) levels at 56 h were lower. The total amount 
of LH and FSH released was 83±20 AU and 1133+261 AU respectively. These values 
were not significantly different from those in experiment 1 with E alone. 
DISCUSSION 
It has been well established that Ρ can exert both facilitory and inhibitory 
effects on ovulation (12,13) and LH release (14,15) in the estrus cycle of 
rats. In the menstrual cycle of rhesus monkeys Ρ can also exert inhibitory 
effects on LH secretion (see Ref. 16 for review). Spies and Niswender (6) 
showed that daily injections of Ρ in the follicular phase of the rhesus monkey 
inhibited the release of LH. This inhibitory effect of Ρ was further investi­
gated by Dierschke et al. (8). They investigated, in the early follicular 
phase, the effects of Ρ on E - induced gonadotropin surges. All Ρ increments 
exceeding the midcycle Ρ concentrations (1 ng/ml) blocked the E -induced gona­
dotropin surges. The midcycle Ρ concentrations also blocked or did not alter 
the E -induced gonadotropin surges. Despite some differences in experimental 
design between our and their experiments (E- and Ρ capsules implanted at the 
same time VS. Ρ capsules implanted 48 h before an E -benzoate injection) the 
results were quite similar. We also observed a blockade of the E -induced 
gonadotropin surges with Ρ increments exceeding the concentration of 1 ng/ml 
(group 1, E- and Ρ implanted at the same time). These results also confirm 
findings of others (7). In our experiments, the midcycle Ρ concentrations sig­
nificantly advanced the gonadotropin peak levels (see Table 1). These peak 
levels, however, were decreased over 50% in 5 out of 7 monkeys in comparison 
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to peak levels obtained previously without P. Thus, it might be concluded that 
Ρ prematurely terminates the surges in this experiment. In our opinion, how­
ever, Ρ advances and decreases the peaks. This is supported by the observation 
that a coincident shift of the gonadotropin induced E peak could be observed 
in this experiment as well as in experiments in which Ρ advances peaks of the 
same or greater magnitude (see Ref. 5 and also Fig. 2). Thus, not only can 
peak levels of LH and FSH be advanced with P, but also threshold levels of 
the gonadotropin that can induce biological effects. The work of Dierschke et 
al. (8) also showed that after 24 h E priming, high increments of Ρ were 
still capable of blocking the E -induced gonadotropin surges in 7 out of 8 
monkeys. We showed previously (5) that midcycle Ρ concentrations exerted an 
optimal facilitating effect on gonadotropin surges after a 46 h E priming. 
Under these conditions it is not known what the effects of high Ρ increments 
on gonadotropin surges are. Therefore we investigated in group 2 the dose de­
pendent effects of Ρ when administered 46 h after E . From Fig. 2 it is ob­
vious that P, administered at the onset of gonadotropin surges, in every in­
vestigated concentration, cannot block these surges anymore, not even by the 
highest supraphysiologicial amount. We therefore conclude that besides a suf­
ficient amount of Ρ also a sufficient duration of the Ρ increment is necessa­
ry to block the E -induced gonadotropin surges. In all experiments, with Ρ 
administered after a 46 h E priming, LH and FSH reached their peak values 
approximately 6 h after the administration of P. This is approximately 17 h 
earlier when compared to the experiment with E alone. Not only was an ad­
vancement of the gonadotropin peak seen but in addition, the gonadotropin 
levels at 52 h were significantly higher than those in the experiment with 
E alone. The amount of gonadotropins released from the pituitary (as judged 
from the areas under the LH and FSH curves) was the same in all these experi­
ments. Thus, the available amount of gonadotropins can be released quicker 
from the pituitary when Ρ is administered at the onset of the E -induced gona­
dotropin surges. In comparison with the peak levels at 72 h obtained with E„ 
alone, the LH and FSH peaks induced with P, were significantly higher at 52 h 
in all experiments except for FSH with the lowest Ρ increment. Therefore, it 
seems likely that FSH can be stimulated further with higher Ρ increments. Up 
to now it is only after ovariectomy that high increments of Ρ have been des­
cribed to facilitate the E -induced gonadotropin surges in rhesus monkeys (7). 
A dose dependent facilitating effect of Ρ on both LH and FSH has been describ­
ed, after ovariectomy, in the human (17) and the rat (18). To our knowledge we 
present the first data with regard to dose dependence of the facilitating 
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effects of Ρ on E -induced gonadotropin release in the intact rhesus monkey. 
In our experiments we can observe a further stimulation of only FSH with high­
er Ρ increments. After this period of facilitated gonadotropin secretion we 
observed lower gonadotropin levels than those observed in the E alone experi­
ment. This effect became more apparent by increasing the Ρ dosage. Thus, in 
these experiments a facilitory phase of Ρ was followed by an inhibitory phase. 
Such a biphasic Ρ effect across time on gonadotropin secretion has been obser­
ved before in rodents (19,20). It is interesting that these negative effects 
of Ρ are sooner observed for LH than for FSH. This may be explained by the 
difference in half time between these hormones (21). In conclusion: when Ρ is 
administered at the onset of the gonadotropin surges, all investigated Ρ con­
centrations accelerated the secretion of the gonadotropins from the pituitary, 
resulting in higher and earlier gonadotropin peaks. The positive facilitating 
effects of Ρ occur rapidly, peaks are observed approximately 6 h after Ρ ad­
ministration, before the inhibitory phase of Ρ can develop . As a result of 
this latter inhibitory Ρ effect, the gonadotropin surges induced with a Ρ in­
crement are terminated quicker than those without a Ρ increment. This latter 
Ρ effect, in combination with the previously mentioned accelerating effect on 
the secretion of the gonadotropins, results in a decrease of the duration of 
the gonadotropin surges. The biphasic Ρ effect on gonadotropin secretion may 
point to a different site of action for the facilitory and inhibitory Ρ 
effects. In the literature we find the following support for this suggestion: 
Ρ receptors have been found in different brain areas: the hypothalamus and the 
pituitary (22-25). The site of action of the negative effect of Ρ seems to be 
localized in the CNS (26-27). Leaving the sensitivity of the pituitary for 
LHRH unchanged (28,29). The positive facilitating effects, may be exerted by 
increasing endogenous LHRH levels (26) most likely in combination with an in­
creased sensitivity of the pituitary for LHRH (30,31). A recent in vitro study, 
using rat anterior pituitary cells in culture, also showed a marked potent­
iation by Ρ of the stimulatory effect of E on both LH and FSH release by a 
direct action at the pituitary level (32). The physiological significance of 
the facilitating effects of Ρ increments higher than 1 ng/ml is not clear at 
present. But, it may be of significance, when more than one follicle is avail­
able for ovulation, thus increasing the preovulatory Ρ concentrations (33,34). 
These increased Ρ levels then do not block but also stimulate the release of 
gonadotropins from the pituitary. The data presented contribute to the know­
ledge of the mechanism of the facilitory effects of Ρ on E„ induced gonado­
tropin surges. In addition, these data further support the hypothesis that Ρ 
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increments at midcycle play a physiological role in the development and term­
ination of the gonadotropin surges (4,5,35,36,37). 
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ABSTRACT 
The specificity of the facilitating effects of progesterone (Ρ) , consisting 
of advancing, increasing, and narrowing of gonadotropin surges, on the estra­
diol (E9)-induced gonadotropin release was investigated in intact female 
rhesus monkeys. All experiments were started at day 3 or 4 of the menstrual 
cycle and were finished 96 h later. Steroids increments were made by implant­
ing sc Silastic capsules containing a crystalline steroid. Three steroids 
were investigated: Androstenedione (Δ) (group 1, n=6), 17a-Hydroxyprogesterone 
(170HP) (group 2, n=6) and 20a-Dihydroprogesterone (group 3, n=9). Three ex­
periments were performed with all animals in each group. In experiment 1, only 
E capsules were implanted (E increments to 250 pg/ml). In experiment 2, a Δ 
(0.9 ng/ml), or a 170HP (0.7 ng/ml) or a 20DHP (1.2 ng/ml) capsule was implan­
ted together with the E capsules. In experiment 3, a Δ, or a 170HP or a 
20DHP capsule was implanted46 h after the E capsules. The results showed that 
a slightly negative effect on gonadotropin secretion could be observed when a 
Δ capsule was implanted in the experiments 2 and 3. The implantation of a 
170HP capsule in experiment 2 and 3 resulted in an advancement of the maximum 
gonadotropin secretion with 12 h. The magnitude of the gonadotropin surges 
was the same in comparison with experiment 1. The implantation of a 20DHP cap­
sule did not modify the gonadotropin surges of experiment 1. Thus, only 170HP 
was able to advance the E -induced gonadotropin surges to a certain extend. 
The other effects of Ρ viz. increasing the gonadotropin levels and decreasing 
the duration of the gonadotropin surges, could not be observed with the ste­
roids investigated. In conclusion: the facilitating effects of Ρ on the E_-
induced gonadotropin surges seem to be a specific phenomenon. 
INTRODUCTION 
Evidence exists that the concentration of several ovarian steroids is in­
creased in the human as well as in the rhesus monkey at midcycle (1-11). In 
two preceding articles we demonstrated a facilitating effect of progesterone 
increments on the estrogen-induced gonadotropin secretion (12,13). This means 
that Ρ was able to advance, increase and narrow the E -induced gonadotropin 
surges after an adequate E priming. The purpose of this study is to investigate 
whether these facilitating effects are specific for P, because "P like" effects 
have been attributed to other ovarian steroids in the human as well as in ani­
mals (14-19). In the present study,we investigated the effects of a periovulat-
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ory androsCenedione, 17a-hydroxyprogesterone, and 20a-dihydroprogesCerone in­
crement on the estradiol-induced gonadotropin secretion in the rhesus monkey. 
MATERIALS AND METHODS 
Female rhesus monkeys having a history of regular menstrual cycles were 
used in this study. Increments of Ε , Δ, 170HP, and 20DHP were made by implant­
ing sc Silastic capsules containing the crystalline steroid. The effective dif­
fusion length of the capsules was 4 cm (E.), 3 cm (Δ), 3 cm (170HP) and also 
3 cm for the 20DHP capsules. In a preceding article (12) we described the con­
struction of the Silastic capsules, the implantation procedure and the blood-
sampling procedure. The effects of three steroids on the E_-induced gonadotro­
pin secretion were studied: Δ (group 1, n=6) ) 170HP (group 2, n=6), and 20DHP 
(group 3, n=9). Three experiments were performed with all animals in each 
group. The experiments were performed at random. In experiment 1, only two E 
capsules were implanted. In experiment 2, a Δ, or a 170HP or a 20DHP capsule 
was implanted at the same time as the E_ capsules. In experiment 3, a Δ, or 
a 170HP or a 20DHP capsule was implanted 46 h after the E. capsules. All ex­
periments started with the implantation of two E capsules between 0900 and 
1000 h on day 3 or 4 of the menstrual cycle. The interval between the experi­
ments and the effect of these experiments on cycle length is identical with 
our previous experiments (13). Bloodsamples during the present experiments 
were drawn just before and 2, 8, 24, 32, 48, 52, 56, 72, 80, and 96 h after 
the implantation of the E capsules. At 96 h after the implantation,the cap­
sules were removed and the final blood sample was taken four hours thereafter. 
Two additional blood samples were drawn at 46 and 50 h in the third experiment 
of each group. In all samples LH, FSH, E and Ρ concentrations were measured 
by RIA. The Δ and testosterone (T) concentrations were measured by RIA, in 
group 1, in the 0, 24, 72, and 100 h sample for which a 4 ml instead of the 
usual 2 ml sample was taken. The 170HP concentrations were measured by RIA in 
all samples of experiment 2 and 3 of group 2. The 20DHP concentrations were 
measured by RIA in all samples of experiment 2 and 3 of group 3. The LH, FSH, 
E„, and Ρ RIA was described previously (12). The E- and Ρ RIA has been modi­
fied in order to measure E., P, 170HP, and 20DHP in one serum sample and will 
therefore be describedagain. The standards used for the LH and FSH RIA were 
LER 1056-C2 and LER 1909-2 respectively. 
The Ε , Ρ, 170HP, and 20DHP RIA 
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The Ε , Ρ, 170ΗΡ, and 20DHP concentrations were measured in the same serum 
sample of 500 μΐ after separating the compounds over two Sephadex LH-20 (Phar­
macia, Uppsala, Sweden) columns. The serum samples (500 \.l) were extracted with 
freshly distilled diethyl ether (2x4 ml) after the addition of 1000 cpm of 
{3H}P and {3H}E and {3H}170HP or {3H}20DHP in order to correct the results 
for procedural losses. The residues of the diethyl ether extracts were taken 
up in 0.2 ml of the eluting solvent {Toluene to methanol (9:1)} and applied 
on the Sephadex LH-20 columns (0.5-хЗО-ст, 0.5 g Sephadex LH-20). P, 170HP, 
and 20DHP were eluted in the first 1.6 ml fraction. The next 0.5 ml fraction 
was discarded, and E« was eluted in the final 2.8 ml fraction. In experiment 
1 of group 1, 2, and,3 the E and Ρ fractions were evaporated to dryness un-" 
der nitrogen and dissolved in 450 μΐ distilled water and 1500 μΐ ethanol resp­
ectively. An aliquot of 150 yl water and of 500 μΐ ethanol was taken in order 
to determine the recovery of the {3H}E (approximately 70%) and the {3H}P 
(approximately 80%), respectively. In experiment 2 and 3 of group 2 and 3 the 
Ρ fraction was evaporated to dryness under nitrogen and dissolved in the elu­
ting solvent {Toluene to methanol (95:5)} and applied on a second Sephadex 
LH-20 column (0.5-x30-cm, 2 g Sephadex LH-20). The first 1.8 ml fraction was 
discarded, Ρ was eluted in the second 1.5 ml fraction. The next 0.7 ml frac­
tion was discarded, and 170HP and 20DHP were eluted in the final 4 ml fraction. 
The Ρ and 170HP or 20DHP fractions were evaporated to dryness under nitrogen 
and dissolved in 1500 μΐ ethanol. An aliquot of 500 μΐ ethanol was taken from 
each fraction in order to determine the recovery of the {3H}P (approximately 
80%) and the {3H}170HP (approximately 90%) or the {3H}20DHP (approximately 90 
% ) . Ρ samples (n=17, range 10-90% B/B ) assayed after one (X) or two (Y) 
chromatographic steps were identical (Y=0.97X-0.1, r=0.99). 
For the E RIA the residues of two 100 μΐ aliquots were dissolved in 50 μΐ 
0.05 M PBS-0.5% gelatin buffer. Then 50 μΐ tracer (10,000 cpm {2,4,6,7-3H}E2; 
SA, 100 Ci/mmol; Radiochemical Centre Amersham, United Kingdom) and 200 μΐ 
1:30,000 rabbit antiserum to 17β-Ε -6-(0-carboxymethyl)-oxime-BSA were added 
to each sample and to the E standards (0, 6.25, 12.5, 25, 50, 100, and 200 pg 
in 50 μΐ 0.05 M PBS-0.5% gelatin buffer). After incubation for 16-20 h at 4 С 
(or 3 h at room temperature), the tubes were placed in an ice bath, and the 
free and bound steroids were separated by adding 1 ml cold dextran-coated char­
coal in PBS buffer. After incubation for 10 min, the tubes were centrifuged at 
3000 rpm for 10 min at 0 C. The supernatant was decanted in vials, and 8 ml 
scintillation fluid (Aquasol NEN Chemicals, Dreieich, West Germany) were added. 
Amounts of E were expressed in pg/ml after correction for water blanks (<5 pg/ 
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tube) and procedural losses. The between and within assay variability of an 
E pool {14A±15 (SD) pg/ml } was 10.6% and 10.5 % respectively (n=15). The E 
pool showed a specific binding of 61% B/B on an average. The slope of the 
curve was 0.96±0.05 (SD). The midrange (50% B/B ) of the curve was 24.9+3.5 
о 
(SD) pg/tube, The least detectable concentration (the concentration resulting 
in a response two standard deviations from the zero dose response) was 1 pg/ 
tube. 
For the Ρ RIA, the residues of two 150 μΐ aliquots were dissolved in 50 μΐ 
0.05 M PBS buffer, and then 50 μΐ tracer (10,000 cpm {1,2,6,7-3H}P;SA, 100 Ci/ 
mmol; Radiochemical Centre) and 200 yl 1:10,000 rabbit antiserum to lia-
hydroxyprogesterone-hemisuccinate-BSA were added to each sample and to the Ρ 
standards (0, 25, 50, 100, 200, 400, and 800 pg in 50 μΐ 0.05 M PBS).The sepa­
ration of free and bound Ρ was identical with the procedure described for the 
E» RIA. Amounts of Ρ were expressed in ng/ml serum after correction for water 
blanks (<5 pg/tube) and procedural losses. The between and within assay varia­
bility of a Ρ pool (3.3±0.4 ng/ml) was 13% and 6.7% respectively. The Ρ pool 
showed a specific binding of 36.6% B/B on an average. The slope of the curve 
was 1.05±0.06. The midrange of the curve was 90+17 pg/tube. The least detect­
able dose was 4 pg/tube. 
For the 170HP RIA we made use of the materials in a commercially available 
17a-hydroxyprogesterone radioimmunoassay kit (Sorin Biomedica, Saluggia, 
Italy). The residues of two 150 μΐ aliquots were dissolved in 300 yl 0.1% 
BSA-PBS buffer. Then 100 μΐ tracer (3,000 cpm {3H} 17a-hydroxyprogesterone) 
and 100 Ml antiserum (the antiserum is raised in rabbits against a 17a-hydroxy-
progesterone-3-conjugate with BSA) were added to each sample and to the 170HP 
standards (0, 12.5, 25, 50, 100, 200, and 400 pg in 300 yl 0.1% BSA-PBS buf­
fer). After incubation for 30 min at roomtemperature and 2 h at 4 C, the tubes 
were placed in an ice bath, and free and bound steroid were separated using a 
procedure identical with the one described for the E RIA. The between and 
within assay variability of a 170HP pool (0.51±0.08 ng/ml) was 15.8% and 14.4% 
respectively (n=10). The 170HP pool showed a specific binding of 62% B/B on 
an average. The slope of the curve was 1.02+0.08. The midrange of the curve 
was 31±8 pg/tube. The least detectable dose was 1.7 pg/tube. Amounts of 170HP 
were expressed in ng/ml serum after correction for water blanks (<2 pg/tube) 
and procedural losses. 
For the 20DHP RIA the residues of two 300 μΐ aliqiots were dissolved in 50 μΐ 
0.05 M PBS-0.5% gelatin buffer. Then 100 yl 1:100 rabbit antiserum (batch 
1277) to 20a-Dihydroprogesterone-3-(0-carboxymethyl)oxime-BSA (Steranti, 
71 
London, Great Britain) was added to each sample and to the 20DHP standards 
(0, 10, 20, 50, 100, 200, and 400 pg in 50 μΐ 0.05 M PBS-0.5% gelatine buf­
fer). Then, after an incubation period of 30 minutes at 4 C, 50 μΐ tracer 
(20,000 cpm 20a -hydroxyU , 2, 6 , 7- 3H}pregn-4-en-3-one ; SA 49 Ci/mmol) was added 
to each tube. After incubation for 2 h at 4 C, the tubes were placed in an ice 
bath, and the free and bound steroids were separated using a procedure ident­
ical with the one described for the E. RIA. The between and within assay vari­
ability of a 20DHP pool (2.1±0.3 ng/ml) was 12.9% and 6.3% respectively. The 
20DHP pool showed a specific binding of 42% B/B on an average. The slope of 
the curve was 1.20±0.07. The midrange of the curve was 110+16 pg/tube. The 
least detectable dose was 9 pg/tube. Amounts of 20DHP were expressed in ng/ml 
serum after correction for water blanks (<10 pg/tube) and procedural losses. 
This method includes the possibility to determine the concentrations of Ε , Ρ, 
170HP, and 20DHP in one sample of 500 μΐ serum. Since 170HP and 20DHP concen­
trations have to be determined in the same fraction, a specific antiserum must 
be used. In order to determine the recovery of 170HP and 20DHP it is suffic­
ient to add either {3H}170HP or {3H}20DHP since both steroids have the same 
recovery (90%). 
All the Δ and Τ concentrations were measured in one assay. For the Δ RIA 200 
μΐ serum samples were extracted with hexane to toluene (80:20) after the addi­
tion of 2500 cpm {3Η}Δ in order to correct results for procedural losses. For 
the Τ RIA, 100 μΐ serum samples were extracted with freshly distilled diethyl 
ether, further a method described elsewhere was followed (20). In both RIAs 
we made use of specific antisera raised in rabbits against androstenedione or 
tes tosterone-7a-carboxylethyl thio ether bovine serum albumine (20). Amounts 
of Δ and Τ were expressed in nmol/1 serum and also in ng/ml for reasons of 
comparison. Statistical methods used for comparison of control and experiment­
al cycles within each group were the nonparametric two tailed Mann-Whitney U 
test and the Student's t test. 
RESULTS 
Group 1 (E VS. E + à) 
Experiment 1 (Fig. 1): In this experiment six monkeys received only E cap-
sules. This resulted in E increments to 256±37 (SD) pg/ml. Ρ levels remained' 
low during the experiment (0.5±0.2 ng/ml). Also the Δ 0.9±0.5 (SD) nmol/1 
(0.3±0.1 ng/ml) and the Τ 0.7±0.5 (SD) nmol/1 (0.2±0.] ng/ml) levels were low 
at 0, 24, 72, and 100 h (see Fig. 1). LH and FSH reached their maximum values 
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67 h after E implantation, the individual results are presented in Table 1. 
The mean maximum increases of LH and FSH above the levels observed at 0 and 
100 h (Δ ) were 614±118 (SE) pg/ml and 7.211.0 μg/ml respectively. The total 
amounts of LH and FSH (expressed as the area under the LH and FSH curve resp­
ectively) were 218±52 (SE) Area Units (AU) and 1763±313 AU respectively. 
Fig. 1. Serum LH, FSH, E , Ρ, Δ, and Τ concentrations in six monkeys after the 
implantation of two E capsules at 0 h (day 3 or 4 of the menstrual cycle) in 
experiment 1, group 1. At 96 h all capsules are removed. 
Experiment 2 (Fig. 2): In this experiment the same six monkeys received, in 
addition to the E capsules, a Δ capsule of 3 cm length. This resulted in E 
increments to 277±13 pg/ml and Δ increments to 3.4+1.4 nmol/1 (1.0±0.4 ng/ml) 
and Τ increments to 2.3+0.6 nmol/1 (0.6+0.2 ng/ml). Ρ levels remained low du­
ring the experiment (0.4±0.1 ng/ml). The time of maximum gonadotropin release 
did not change when compared to experiment 1 (see Table 1 for individual re­
sults). In 5 out of 6 monkeys a decrease of the Δ LH and the Δ FSH could 
_ max max 
be observed. On the average Δ LH declined to 492 + 114 pg/ml and S" FSH to 
ь
 max
 r b
 max 
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5.3+0.6 vg/ml (P<0.05 for bothIE and FSH). In this experiment, the total 
amounts of LH and FSH released, had decreased to 118±28 AU (P<0.025) and 
13031137 AU respectively, but this latter observation is not significant 
(0.05<P<0.10). At 72 h LH (P<0.05) and FSH (P<0.025) levels were lower than 
those observed in experiment 1. 
Fig. 2. Serum LH, FSH, E„, Ρ, Δ, and Τ concentrations in six monkeys after the 
implantation of two E„ capsules and a Δ capsule at 0 h in experiment 2, group 
1. See legend to Fig. 1 for further details. 
Experiment 3 (Fig. 3): In this experiment, in the same six monkeys, a 3 cm" 
capsule was implanted 46 h after the E capsules. E. levels during the experi­
ment were 277+44 pg/ml. The Δ levels were increased after 46 h to 2.8+1.5 
nmol/1 (0.810.4 ng/ml) and Τ levels to 1.9+0.7 nmol/1 (0.5±0.2 ng/ml). Ρ levels-
remained low during the experiment (0.5±0.2 ng/ml). The time of maximum gona­
dotropin release did not change when compared to experiment 1 (see Table 1 for 
individual results). The Δ LH (588±107 pg/ml) and the Δ FSH (6.3-1.5 ug/ 
max
 r
 max
 и & 
ml) were not significantly lower when compared with experiment 1. The total 
amounts of LH (143±36 AU, P<0.05) but not FSH (1502±231 AU, P>0.10) had decrea-
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sed. At 72 h LH ( P<0.005) and FSH (P<0.025) levels were lower than those ob­
served in experiment 1. 
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Fig. 3. Serum LH, FSH, Ε , Ρ, Δ, and Τ concentrations in six monkeys after the 
implantation of two E capsules at 0 h and a Δ capsule at 46 h in experiment 3, 
group 1. Two additional bloodsamples have been drawn in this experiment at 46 
and 50 h, in comparison to experiment 1 and 2. See legend to Fig. 1 for further 
details. 
Group 2 (E vs. E2 + 170HP) 
Experiment 1 (Fig. 4): In this experiment, six monkeys received only E capsul­
es. This resulted in E increments to 247±33 (SD) pg/ml. Ρ levels remained low 
during the experiment {0.4±0.1 ng/ml (SD)}. LH and FSH reached their maximum 
values 67 h after the implantation of the E capsules; the individual results 
are presented in Table 2. The mean maximum increases of LH and FSH were 679+104 
(SE) pg/ml and 7.1±1.1 ug/ml respectively. The total amounts of LH and FSH re­
leased werel74±52 (SE) AU and 1868±342 AU respectively. 
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Table 1 The time of maximum LH and FSH values in the E control cycles and in 
the study cycles with Δ added at the same time (E + Λ) and 46 h after E 
(E2 + Δ-> 46) 
Monkey 
(no.) 
E
, 
56 
72 
56 
72 
72 
72 
671 
control 
(h) 
Ε + Δ 
(h) 
56 
52 
72 
72 
52 
52 
592 
E + Δ->·46 
(h) 
F4 
160 
G37 
2781 
F49 
154 
Mean 
52 
72 
72 
56 
72 
52 
63 z 
•This difference in time is nonsignificant 
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Fig. 4. Serum LH, FSH, E,, and Ρ concentrations in six monkeys after the im­
plantation of two E capsu] 
Fig. 1 for further details. 
les at 0 h in experiment 1, group 2. See legend to 
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Experiment 2 (Fig. 5): In this experiment, the same six monkeys received, in 
addition to the E capsules, a 170HP capsule of 3 cm length. This resulted in 
E„ increments to 253±41 pg/ml and 170HP increments to 0.710.2 ng/ml. Ρ levels 
remained low during the experiment (0.2+0.1 ng/ml). The time of maximum gona­
dotropin release was advanced (P<0.02) by 12 h to 55 h after the E7+170HP 
implantation (see Table 2 for individual results). The Λ LH (733±103 pg/ml) r
 _ max 
and Δ FSH (6.3±1.1 Mg/ml) did not change when compared with experiment 1. 
Also the total amount of gonadotropins released (LH; 188^17 AU, and FSH; 
1552+257 AU) was the same in this experiment. At 72 h LH (P<0.025) but not 
FSH (P>0.10) levels were lower than those in experiment 1. 
Rh-LH Rh-FSH 
( p g / m l ) n = 6 (fjglmi) 
Estradiol 
ipg/ml)o- Progeslerone • i(ng/ml) 
17-OH Ρ 
(ng / m l ) · 
2 0 -
0 20 40 60 80 100 
time {hi 
Fig. 5. Serum LH, FSH, E , Ρ, and 170ΗΡ concentrations in six monkeys after 
the implantation of two E capsules and a 170HP capsule at 0 h in experiment 
2, group 2. See legend to Fig. 1 for further details. 
Experiment 3 (Fig. 6): In this experiment, in the same six monkeys, a 3 cm 
170HP capsule was implanted 46 h after the E„ capsules. E levels during the 
experiment were 281±52 pg/ml and 170HP levels were increased after 46 h to 
0.7±0.1 ng/ml. The time of the maximum gonadotropin release was advanced 
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(Р<0.05) by 12 h to 55 h after the E implantation (see Table 2 for indivi­
dual results). Ρ levels remained low during the experiment (0.2±0.1 ng/ml). 
The Δ LH (659±133 pg/ml) and the Δ FSH (7.4±1.1 μg/ml) did not change 
max max 
significantly when compared with experiment 1. Also the total amountsof gona­
dotropins released (LH; 123±24 AU, and FSH; 1380±210 AU) did not change signi­
ficantly from the values observed in experiment 1. At 72 h LH (P<0.005) but 
not FSH levels were lower than those in experiment 1. 
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Fig. 6. Serum LH, FSH, E , Ρ, and 170ΗΡ concentrations in six monkeys after 
the implantation of two E capsules at 0 h and a 170I1P capsule at 46 h in exp­
eriment 3, group 2. Two additional bloodsamples have been drawn at 46 and 50 h 
in this experiment, in comparison to experiment 1 and 2. See legend to Fig. 1 
for further details. 
Group 3 (E vs. E + 20DHP) 
Experiment 1 (Fig. 7) : In this experiment, nine monkeys received only E cap­
sules. This resulted in E„ increments to 287±44 (SD) pg/ml. Ρ levels remained 
low during the experiment (0.4+0.1 ng/ml). LH and FSH reached their maximum 
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values 67 h after E implantation; the individual results are presented in 
Table 3. The mean maximum increases of LH and FSH were 482±119 (SE) pg/ml and 
5.4±1.0 yg/ml respectively. The total amounts of LH and FSH released were 92+ 
34 (SE) AU and 12521206 AU respectively. 
Table 2. The time of maximum LH and FSH values in the E control cycles and 
in the study cycles with 170HP added at the same time (E- + 170HP) and 46 h 
after E 2 (E + 170HP->-46). 
Monkey 
(no.) 
138 
H52 
160 
J2 
J12 
G37 
Mean 
E
, 
56 
72 
72 
72 
72 
56 
671 
control 
(h) 
E + 170HP 
(h) 
56 
56 
52 
56 
56 
52 
552 
E2 + 
56 
56 
50 
56 
56 
56 
553 
170HP->-46 
(h) 
1
>
2
>
3This difference in time is significant (1·2Ρ<0.02 and 1 , 3P<0.05 ) two 
tailed Mann Whitney U-test). 
Table 3. The time of maximum LH and FSH values in the E. control cycles and 
in the study cycles with 20DHP added at the same time (E + 20DHP) and 46 h 
after E 2 (E2 + 20DHP-Î-46). 
Monkey 
(no.) 
J2 
2843 
J12 
139 
2836 
2769 
J5 
154 
162 
Mean 
E 9 
72 
48 
72 
80 
56 
56 
72 
72 
72 
671 
control 
(h) 
E 2 + 20DHP 
(h) 
56 
56 
56 
56 
52 
72 
56 
56 
72 
592 
E2 + 
52 
56 
56 
72 
72 
72 
80 
72 
72 
672 
20DHP-*46 
(h) 
»This difference in time is nonsignificant 
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Fig. 7. Serum LH, FSH, E„, and Ρ concentrations in nine monkeys after the im­
plantation of two E, capsules at 0 h in experiment 1, group 3. See legend to 
Fig. 1 for further details. 
Experiment 2 (Fig. 8): In this experiment, the same nine monkeys received, in 
addition to the E capsules, a 20DHP capsule of 3 cm length. This resulted in 
E increments to 259+33 pg/ml and 20DHP increments to l.liO.l ng/ml. Ρ levels 
remained low during the experiment (0.2±0.1 ng/ml). The time of maximum gona­
dotropin release was at 59 h after E implantation and did not change signifi­
cantly from values observed in experiment 1 (see Table 3 for individual res-
suits). This holds also true for the other parameters studied: Δ LH (563± 
_ max 
102 pg/ml), Δ FSH (5.3±1.4 pg/ml), Ιϊϋ' LH (130±27 AU) , andini FSH (1172 
±281 AU). 
Experiment 3 (Fig. 9): In this experiment, in the same nine monkeys, a 3-cm 
20DHP capsule was implanted 46 h after the E capsules. E levels during the 
experiment were 262±48 pg/ml and 20DHP levels were increased after 46 h to 
1.3±0.2 ng/ml. Ρ levels remained low during the experiment (0.2±0.1 ng/ml). 
As in experiment 2, none of the parameters studied, viz. time of maximum 
80 
gonadotropin release (at 67 h, see Table 3 for individual results), Δ LH 
(615±126 pg/ml), Δ FSH (6.9.12.4 ug/ml), area LH (13U34 AU), and area FSH 
max 
(14171409 AU) changed significantly from the values observed in experiment 1. 
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Fig. 8. Serum LH, FSH, E , Ρ, and 20DHP concentrations in nine monkeys after 
the implantation of two E capsules and a 20DHP capsule at 0 h in experiment 
2, group 3. See legend to Fig. 1 for further details. 
Пгзаивзгоп 
Facilitory effects of progesterone on ovulation and gonadotropin secretion 
have been described by several authors in several species under various con­
ditions (12-15, 21-31). In a previous article,we demonstrated that P, in peri-
ovulatory concentrations, was able to advance, to increase, and to narrow the 
E -induced gonadotropin surges after a sufficient E priming (12). Furthermore, 
we demonstrated that P,when administered at the onset of the E -induced gona­
dotropin surges, in all investigated concentrations (1-25 ng/ml) accelerated 
the secretion of the gonadotropins from the pituitary, resulting in higher, 
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Fig. 9. Serum LH, FSH, E., P, and 20DHP concentrations in nine monkeys after 
the implantation of two E„ capsules at 0 h and a 20DHP capsule at 46 h in ex­
periment 3, group 3. Two additional bloodsamples have been drawn at 46 and 
50 h in this experiment, in comparison to experiment 1 and 2. See legend to 
Fig. 1 for further details. 
earlier, and narrower gonadotropin peaks (13). In the present study, we inves­
tigated the effects of three other ovarian steroids, namely Δ, 170HP, and 20DHP, 
which change their serum concentrations during the periovulatory phase in the 
human and in monkeys (1-11). The levels of Δ increase from 1.69 ng/ml, in the 
follicular phase, to 1.93 ng/ml, in the periovulatory phase, in the human (3). 
In the baboon Δ increases from 0.4 ng/ml to 0.8 ng/ml (32). In our experiments 
we increased the Δ levels from 0.9 nmol/1 (0.3 ng/ml) to 3.2 nmol/1 (0.9 ng/ 
ml). Thus, our experimental increments in the rhesus monkey are in good agree­
ment with the physiological increments during the menstrual cycle of the ba­
boon. A concomitant rise of the Τ levels with the Δ levels in the periovulato­
ry phase has been observed in the human as well as in the monkey (3, 10, 32). 
The major part of this Τ increase is due to a peripheral conversion from Δ to 
Τ (3). Also in our experiments, Τ rises concomitantly with Δ. The effects of Τ 
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on E -induced gonadotropin surges in the female monkey (Maaaaa nemestrina) 
were investigated by Steiner et al. (33). They found that a variety of Τ 
treatment regimens in ovariectomized monkeys did not alter the dynamics of 
the E -induced gonadotropin surges. If these results hold also true for the 
intact rhesus monkey the negative effects of the Δ increments observed in our 
experiments are not due to Τ but to Δ itself or some other metabolite of Δ. 
However, differences in feedback systems may occur between intact and ovari­
ectomized monkeys (29). Furthermore, we found that the negative effects of 
the androgen increments were more obvious for LH than for FSH. This latter 
observation is in good agreement with the effects of androgens on rat anter­
ior pituitary cells in primary culture (34-35). So far , only suppressive nega­
tive, effects of androgens on the secretion of gonadotropic hormones have 
been discussed. In the immature rat, Ρ was able to induce LH and FSH surges 
after an E priming as well as after an androgen priming (36), suggesting a 
role for androgens in the triggering of puberty. In a nonmammalian species, 
the hen, it was found that Δ was able to advance ovulation (19) suggesting a 
"P like" effect of Δ. The administration of Δ in the rat decreased the rate 
of ovulation (37) and the active immunization of sheep against Δ produced an 
opposite effect (38,39). These results may be explained by a direct effect of 
Δ on the gonadotropin secretion or by a role of androgens in follicular matu­
ration or atresia (40-45). The latter possibility seems to be most plausible, 
in our opinion. The serum levels of 170HP increase from 0.3 ng/ml in the fol­
licular phase to 1-2 ng/ml on the day of the LH peak (1, 2, 4, 5, 6, 8). It 
has been suggested that 170HP could be used as an index of follicular matur­
ation and may play a role in the midcycle gonadotropin surge (1). Later on, 
in the ovariectomized rat (15) and in the eugonadal woman (14) 170HP was found 
to be ineffective in modifying the E -induced gonadotropin surge. In both ex­
periments, however, large quantities of 170HP were used. In our experiments we 
made a small, physiological, increment of 170HP from 0.2 ng/ml to 0.7 ng/ml 
and we found that 170HP was able to advance the E -induced gonadotropin peaks 
by 12 h. P, under the same conditions, was able to advance the E -induced 
gonadotropin peaks by 17 h (12). This suggests that Ρ is more potent than 
170HP in advancing the E -induced gonadotropin peaks. NeverthelesSj170HP may 
synergise with Ρ in modulating the E -induced gonadotropin surges at midcycle. 
In contrast to Ρ (12), 170HP could not influence the magnitude of the surges. 
After a 46 h E priming, Ρ but not 170HP was able to increase the secretion of 
gonadotropins. In the 170HP experiments, it is interesting to note that LH but 
not FSH levels were significantly decreased after the advanced surges. 
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Although the increase of 20DHP levels during the periovulatory phase in the 
human is minor (4, 47), 20DHP is regarded to play an important role on gona­
dotropin secretion in rodents (15-17). In the rabbit, Milliard et al. (15) 
demonstrated a prolonged LH surge by the action of 20DHP. Later on, Young Lai 
could not confirm their results in the same species (46). In E primed, ovari-
ectomized rats, supraphysiological amounts of 20DHP were able to induce an LH 
and an FSH surge (15). Leyendecker et al. (14) demonstrated that in one out 
of two eugonadal women, large quantities of 20DHP were able to trigger an LH 
and an FSH surge. In our experiments, we made a small increment of 20DHP from 
0.3 ng/ml to 1.2 ng/ml, an increment similar to the one previously used to in­
vestigate the facilitating effects of P. This increment of 20DHP was not able 
to alter the dynamics of the dynamics of the E -induced gonadotropin surges. 
It is our conclusion from our experimental findings in the rhesus monkey, to­
gether with the slow midcycle increase of 20DHP in the human (4, 47) that 
20DHP does not play an additional role in modifying the midcycle gonadotropin 
surge in the primate. It has recently been reported that rat pituitary and 
brain tissues are able to metabolize progesterone to e.g. 5oi-dihydroprogest-
erone. This metabolite of Ρ can be selectively accumulated in the hypothalamus 
and the pituitary but not in the uterus. Furthermore, it has been reported 
that this metabolite of Ρ has "P like" effects on gonadotropin secretion and 
ovulation (for review see Refs. 48 and 49). Our study does not exclude the 
possibility that the conversion of Ρ to 5a-dihydroprogesterone may be an im­
portant component of the molecular mechanisms whereby progesterone exerts its 
effects on gonadotropin secretion. Our data do suggest that the facilitory 
effects of Ρ on the E -induced gonadotropin surge are specific ones, if the 
effects of the steroids investigated on the gonadotropin surge are compared 
with those previously demonstrated for Ρ (12, 13). That is, none of the ster­
oids investigated was able to advance, and to increase, and to narrow the E -
induced gonadotropin secretion as has been demonstrated before for Ρ (12, 13). 
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ABSTRACT 
In a previous study (Helmond et al. Endocrinology 107:478, 1980) we invest­
igated the effects of an estradiol (E,) or E and progesterone (P) increment 
in the early follicular phase on their ability to modify the gonadotropin se­
cretion. We found that Ρ was able to advance the E -induced gonadotropin sur­
ges. This study deals with the effects of similar steroid increments in the 
midfollicular phase and with the effects of such treatment in both the early 
and midfollicular phase on subsequent hormonal patterns and cycle length. In 
the early follicular phase,the length of the 7 experimental cycles investiga­
ted increased by 13 days. This prolongation was caused by an extension of 
the follicular phase. After cessation of the treatment, the E„ levels were 
significantly lower than those observed before the treatment. The time inter­
val between the day of cessation of the treatment and the day of the spontan­
eous gonadotropin surge is about 18 days. It is suggested that this time in­
terval represents the duration of a follicle to become mature. After the spon­
taneous gonadotropin surge, a luteal phase indistinguishable from normal could 
be observed. The hormonal patterns during the last 28 days of the prolonged 
cycles were not different from those in normal cycles. Similar experiments, E. 
(n=7) or E- and Ρ (n=7) treatment, performed in the midfollicular phase showed 
that the E -induced gonadotropin surge could be advanced by Ρ by 11 h, just 
as in the early follicular phase. Subsequent hormonal patterns showed that the 
E_-induced gonadotropin surges were followed by luteal phases with either a nor­
mal length and a normal Ρ increment (n=2), or a normal length and a subnormal 
Ρ increment (n=7) or with a very short length without a Ρ increment (n=5). In 
these luteal phases the time courses of the FSH and E concentrations seemed 
to deviate from those observed in the luteal phases of normal menstrual cycles. 
These results demonstrate that follicle growth and corpus luteum function in 
the rhesus monkey can be modified experimentally by changing the timing of the 
gonadotropin peaks. 
INTRODUCTION 
In the early seventies some observations were made with regard to the effects 
of estrogen administration on subsequent hormonal patterns in the human mens­
trual cycle (1-3). It was found that the administration of estrogens was effect­
ive in changing the pattern of the gonadotropin secretion. This effect depend­
ed on the dosage used and the day of administration in the menstrual cycle. In 
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the rhesus monkey, the strength and duration characteristic of the estrogen-
induced gonadotropin surge was thoroughly investigated by Karsch et at. (4). 
Only limited data are available with regard to the hormonal patterns following 
these surges. In the rhesus monkey, Yatnaji et al. (5) showed that after an 
estradiol-benzoate injection at day three of the cycle the E,-induced gonado­
tropin surges are followed by decreased E levels. Preliminary data by Clark 
et al. suggest that these lower E levels are a consequence of the disruption 
of the follicular maturation. The present study deals with a detailed invest­
igation of the hormonal patterns subsequent to steroid treatment in the early 
and midfollicular phase. 
MATERIALS AND METHODS 
Female rhesus monkeys having a history of regular menstrual cycles were used 
in this study. The present study deals with the hormonal patterns subsequent 
to steroid treatments in the early follicular phase and the hormonal patterns 
before, during , and subsequent to steroid treatment in the midfollicular phase. 
The hormonal patterns during steroid treatments in the early follicular phase 
were previously described in detail (7, 8). 
In the early follicular phase, the experiments (n=7) started at day 3 or 4 of 
the menstrual cycle and lasted for 96 h. Table 1 presents the kind of experi­
ments these monkeys were subjected to in this study. After cessation of the 
treatment blood samples were drawn daily until the next menses. 
In the midfollicular phase, two series of experiments were performed with 
seven monkeys each. The experiments started at day 7 or 8 of the menstrual 
cycle. The interval between the two series of experiments was at least two 
months. In the first series, seven monkeys received two E capsules between 
0900 and 1000 h. In the second series, the same seven monkeys received a Ρ cap­
sule, 24 h after the implantation of the E capsules. Bloodsamples were drawn 
just before, and 2, 8, 24, 28, 32, 48, 52, 56, 72, 80, and 96 h after the im­
plantation of the E capsules. All capsules were removed 96 h after the implant­
ation of the E- capsules, and a blood sample was taken four hours thereafter. 
After this, daily blood samples were drawn until the next menses. 
In all samples the LH, FSH, E , and Ρ concentrations were measured by RIA, 
using methods described previously (7). The standards used for LH and FSH were 
LER 1909-2 and LER 1056-C2 respectively. In a preceding article we described 
the general care of the animals, the construction of the Silastic capsules, the 
implantation procedure and the bloodsampling procedure (7). 
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Analysis of hormonal data 
For reasons of comparison, logarithmic transformations were performed on the 
LH, FSH, and Ρ data, and a square root transformation on the E data. These 
transformed data are presented in Fig. 1 and Fig. 2 and have also been used to 
calculate the data presented in the Tables 2, 3, 4, 5, 6, 8, and 9. The stat­
istical tests used to analyse the data were the same as described previously 
(9). Fisher's exact probability test for consistency between two dichotome 
distributions was added in order to analyse the difference in the frequency 
of occurrence of a phenomenon between the normal and experimentally altered 
cycles. The paired Student's t test and Mann-Whitney U test were added in 
order to analyse every other difference between the normal and altered cycles. 
The level of significance for all tests was set at the 5% level. 
RESULTS 
Experiments in the early follicular phase 
In Table 1,the kind of experiment performed on day 3 or A of the menstrual 
cycle and the effects of these experiments on some properties of the menstrual 
cycle of the monkeys are shown. In 6 out of 7 experiments the steroid treat­
ment resulted in an induction of LH and FSH surges. In the remaining experi­
ment, the luteal Ρ concentrations completely blocked the E -induced gonadotrop­
in surge (Table 1, monkey 154, exp 2xE +4cm P). 
Svbsequent hormonal patterns 
In all experiments, the length of the menstrual cycle was increased by about 
13 days. This extension was due to an increase in length of the follicular 
phase. It is of interest to note that the time interval from the day of cessat­
ion of the treatment to the day of the spontaneous gonadotropin surge is about 
18 days (Table 1). The mean patterns of LH, FSH, E , and Ρ from the day of 
cessation of the treatment to the day before the next menses are shown in Fig. 
1. The hormonal profiles of a representative subject, including steroid treat­
ment and its effect on gonadotropin secretion, are shown in Fig. 2. Note that 
E. levels after treatment are lower than those observed before treatment. This 
is significant for all monkeys {58+15 (SE) pg/ml VS. 102=10 pg/ml, P<0.05
>
 two 
tailed paired t test}. A tendency towards increasing gonadotropin levels, pos­
sibly resulting from these low E levels, can be observed after cessation of 
the treatment. This observation is significant for FSH (see Fig. 1 and 2 and 
also Table 6). The last 28 days of the prolonged cycles showed hormonal patterns 
92 
Table 1. Data of 7 monkeys treated with various E and Ρ combinations on day 3 or 4 of the menstrual cycle. 
Control cycle Treatment cycle 
Monkey Length LH surge Luteal phase Treatment Length "Follicular phase"1 LH surge Luteal phase 
(no.) (days) (day) (days ) (days) (days) (day) (days) 
14 14 2xE 2 41 20 
14 14 2xE2+4cm-P 41 20 
12 16 2xE +P-*46lt 40 17 
11 14 2xE„ 40 16 
154 
154 
138 
F49 
2836 
2769 
162 
28 
28 
28 
25 
31 
26 
30 
2 
 +4
46lt 
2 
2xE +P->-325 
2xE +P-K325 
2xE2+P+46
i
* 
41 
41 
39 
41 
27 
27 
24 
24 
24 
24 
25 
14 
14 
16 
16 
17 
15 
16 
13 18 + t :> 18 
11 15 5 17 
13 17  +P+ i 18 
Mean±SD 28.012.1 12.6±1.3 15.4±1.6 40.7ìl.36 18.0±1.56 25.0±1.46 15.4±1.17 
This "follicular phase" is defined as the interval between the day of the LH surge and the day of cessation of 
treatment. 
22xE. = two E capsules implanted for 96 h, E levels ±250 pg/ml. 
32xE.+4cm-P = implantation of a 4-cm Ρ capsule at the same time as the E capsules; Ρ levels ±5 ng/ml. 
''гхЕ^+Р^б = implantation of a 1-cm Ρ capsule 46 h after the E. capsules; Ρ levels ±1 ng/ml. 
2χΕ„+Ρ-»·32 = implantation of a 1-cm Ρ capsule 32 h after the E capsules; Ρ levels il ng/ml. 
6Significantly different from control cycles P<0.001, paired t test. 
Not significantly different from control cycles. 
Τ ~ τ • —> τ г 
BOO η 
-
6 0 0 -
400-
200-
-
(п.7) 
Ê I 
^^гШ, ι „_ лт 
Hwwmmr^^^^gi 
Progesterone (ng/ml) 
11.0 
(п.7) 
9.0 
-16 -12 -θ - i 0 .A »β «12 «16 
94 
Fig. 1. The patterns of LH, FSH, E , and Ρ subsequent to steroid treatment in 
7 rhesus monkeys. The arrow indicates the day when all capsules were removed. 
For each hormone the geometrical mean is represented, except for E, for which 
the mean after a square root transformation is represented. Each point is the 
mean of seven observations and the 95% confidence limit of the mean is indicat­
ed by the solid vertical lines. The day of the LH and FSH peak (day 0) is ta­
ken as the point of reference, except for the first 9 and the last 4 days for 
which the day of cessation of treatment (see arrow) and the first day of mens­
truation is the point of reference. The shaded areas are the range of the nor­
mal values for the presented hormones. 
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Fig. 2. The patterns of LH, FSH, E , and Ρ in monkey F49 during a menstrual 
in which two E capsules are inserted at day 4 and removed at day 8 (see 
arrows). 
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1.12 
2.15 
19.66 
1.61 
2.31 
2.15 
NS.?-
F<0.01 
P<0.001 
NS. 
P<0.005 
P<0.01 
4/73 
7/73 
7/7З 
З/7З 
5/7З 
4/73 
(17/20) 
(16/20) 
(20/20) 
(12/20) 
(10/20)1* 
(іо/го)1* 
Table 2. Significance of differences between cycle days of LH, as established 
by the calculation of contrasts, and their incidence in 7 experimentally pro-
longed menstrual cycles. 
Contrasts between cycle days F value Significance Incidence 
prolonged normal 
4· -11 to -2 VS. -1 
Ψ +2 to +16 vs. +1 
+ -1 and +1 WS. 0 
+ -11 to -2 vs. +2 to +16 
+ -11 to -7 vs. -6 to -2 
t +2 to +9 vs. +10 to +16 
^ata are from Heimond et- al. (9). 
zNonsignificant 
Not significantly different from the normal frequency (in parentheses). 
Nonsignificant observation in 20 normal menstrual cycles. 
The arrow indicates whether the first part of the contrast is higher (O or 
lower (+) than the second part. 
Table 3. Significance of differences between cycle days of FSH, as established 
by the calculation of contrasts, and their incidence in 7 experimentally pro-
longed menstrual cycles. 
Contrasts between cycle days F value Significance Incidence 
prolonged normal 
4- -6 to -2 ys. -1 
+ +2 to +8 ys. +1 
+ -1 to +1 ys. 0 
+ -6 and-2 ys. +2 to +8 
+ -11 to -7 ys. -6 to -2 
+ +2 to +4 ys. +5 to +8 
+ +8 to +11 ys. +12 to +16 
+ +2 to +6 ys. +7 to +11 
+ +7 to +11 ys. +12 to +16 
Ψ +8 ys. +13 
iData are from Heimond et al. (9). 
2Nonsigni ficant 
^Not significantly different from the normal frequeny (in parentheses) 
^Nonsignificant observation in 20 normal menstrual cycles. 
The arrow indicates whether the first part of the contrast is higher (t) or 
lower (+) than the second part. 
0.80 
1.94 
15.68 
0.67 
1.94 
0.36 
10.11 
2.22 
8.50 
1.36 
NS. 2 
P<0.025 
P<0.001 
NS. 
P<0.025 
NS. 
P<0.001 
P<0.005 
P<0.001 
NS. 
5/7З 
6/7З 
7/73 
З/7З 
7/7З 
S/?3 
7/7З 
4/73 
7/7З 
7/7З 
(14/20)" 
(17/20) 
(20/20) 
(11/20)4 
(18/20) 
(13/20) 
(19/20) 
(15/20) 
(19/20) 
(15/20) 
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Table 4. Significance of differences between cycle days of Estradiol, as estab­
lished by the calculation of contrasts, and their incidence in 7 experimentally 
prolonged menstrual cycles. 
Contrasts between cycle days F value Significance Incidence 
prolonged normal1 
t -11 to -7 ws. -6 to -1 
± -11 to -6 vs. -5 
4· +1 to +6 vs. +7 to +11 
+ +7 to +11 vs. +12 to +16 
4- +2 to +6 vs. +1 to +16 
^ata are from Heimond et al. (9). 
2Nonsignificant 
Not significantly different from the normal frequency (in parentheses) 
Nonsignificant observation in 20 normal menstrual cycles. 
The arrow indicates whether the first part of the contrast is higher (+) or 
lower ( + ) than the second part. 
40.39 
3.26 
1.99 
4.88 
5.45 
P<0.001 
P<0.001 
P<O.Q25 
P<0.001 
P<0.001 
7/73 
6/7З 
6/7З 
6/7З 
6/7З 
(19/20) 
(16/20) 
(16/20) 
(.11/ZO)1* 
(18/20) 
Table 5. Significance of differences between cycle days of Progesterone, as 
established by the calculation of contrasts, and their incidence in 7 experi-
mentally prolonged menstrual cycles. 
Contrasts between cycle days F value Significance Incidence 
prolonged normal 
t -11 to -7 vs. -6 to -1 
t O us. -1 
+ -1 vs. -2 
+ 0 vs. +1 
+ +1 to +6 ys. +7 to +11 
4 +7 to+ 11 vs. +12 to +16 
^ata are from Heimond et al. (9). 
2Nonsignificant 
3Not significantly different from the normal frequency (in parentheses). 
'•Nonsignificant observation in 20 normal menstrual cycles.1 
The arrow indicates whether the first part of the contrast is higher (Ό or 
lower (Ό than the second part. 
1.25 
18.47 
0.18 
0.46 
3.60 
53.48 
NS.2 
P<0.001 
NS. 
NS. 
p<o.ooi 
P<0.001 
5/73 
7 / 7 3 
4/73 
4/73 
6/7З 
7/7З 
(12/20)1* 
(17/20) 
(14/20) 
(12/20)ц 
(19/20) 
(20/20) 
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Table 6. The correlation between hormones and their incidence in 7 prolonged menstrual cycles. 
Correlations between X and Y Incidence of the sign of the r value Sign test 
on the indicated days and its significance in individuals 
X. Days P<0.05 P<0.05 Ρ value 
Analyzing all pairs 
Ρ value 
Days, 
Days, 
Days,, 
V 
p . 
LH 
FSH 
E2 
FSH 
FSH 
-11 
+2 
-17 
-11 
+2 
+ 8 
-17 
-11 
-17 
-11 
+ 2 
to 
to 
to 
to 
to 
to 
to 
to 
to 
to 
to 
-2 
+16 
-12 
-2 
+ 8 
+ 16 
-12 
E 2 peak 
-12 
-2 
+ 16 
1 
2 
5 
0 
3 
7 
4 
7 
6 
0 
2 
0 
1 
2 
0 
0 
5 
4 
6 
0 
0 
0 
6 
5 
2 
7 
4 
0 
3 
0 
1 
7 
5 
2 
2 
0 
1 
0 
0 
0 
0 
0 
1 
0 
NS. 1 2 
NS. 2 
NS.3 
P<0.05k 
NS.2 
Р^.ОЗ
1
* 
NS. 3 
Р<0.05ц 
NS.3 
P<0.05lt 
NS.1* 
-0.211 
-0.164 
+0.269 
-0.187 
-0.063 
+0.364 
+0.374 
+0.691 
+0.121 
-0.428 
+0.165 
70 
105 
42 
70 
49 
63 
42 
81 
42 
70 
J05 
NS. 2 
NS. 2 
NS. 3 
NS.1· 
N S . 2 
Р<0.01 ц 
P<0.02 3 
P<0.Q01k 
NS.3 
P<Q.001k 
NS.'1 
NS. = nonsignificant 
Nonsignificant observation in 20 normal menstrual cycles (see ref. 9) 
No comparable data available in normal menstrual cycles 
Significant observation in 20 normal menstrual cycles (see ref. 9) 
remarkably similar to those observed previously in 20 normal menstrual cycles 
(9). The correlations between the mean hormonal concentrations in the normal 
and prolonged menstrual cycles were highly positive and highly significant: 
LH, r= +0.915 Р<0.001; FSH, r= +0.979 ."<0.001; E , r= +0.960 Ρ<0.001; Ρ, г= 
+0.960 Ρ<0.001. A more detailed comparison was also made and these results are 
presented in the Tables 2 to 6. Some observations that were significant in the 
previously analysed 20 normal menstrual cycles were not significant in the 7 
prolonged cycles. This may be explained by the different number of cycles ana­
lysed (20 VS. 7). Three contrasts were significant in the prolonged cycles but 
not in the normal cycles: the contrast between E on days +7 to +11 VS. +12 to 
+16 (Table 4), the contrasts between LH on days -11 to -7 vs. -6 to -2 and days 
+2 to +9 VS. +10 to +16, Table 2. The frequency of occurrence of these con­
trasts was not different in the normal and the prolonged cycles (Fisher's ex­
act probability test, P>0.05). 
Experiments in the midfollicular phase 
In the first experiment, seven monkeys received two E» capsules at day 7 or 
8 of the menstrual cycle. This resulted in E. increments to 280±36 (SD) pg/ml. 
Ρ levels remained low during the experiment {0.5±0.2 (SD) ng/ml}. LH and FSH 
reached their maximum values 53±4 (SD) h after E implantation. The mean max­
imum increases of LH (Δ LH) and FSH (Δ FSH) above the values observed at 
max max 
0 and 100 h were 9561170 (SE) pg/ml and 9.6±1.6 pg/ml respectively. The total 
amounts of LH and FSH released (expressed as the areas under the LH and FSH 
curves respectively) were 227±48 (SE) Area Units (AU) and 2276±288 AU respect­
ively . 
In the second experiment, the same seven monkeys received in addition to the 
two E capsules, a 1-cm Ρ capsule, which was implanted 24 h after the E cap­
sules. The E. levels during the experiment were 252±43 pg/ml and Ρ levels 
after 24 h were 1.1±0.1 ng/ml. The time of the maximum gonadotropin release 
was at 42±10 h after E„ implantation and was significantly earlier than in the 
first experiment (two tailed Mann-Whitney U test, P<0.02). The Δ LH (742±63 
_ max 
pg/ml) and the Δ FSH (11.0+2.1 Mg/ml) were not significantly different from 
r
 max "
 J 
the first experiment. The same holds true for the total amounts of LH and FSH 
released (190+32 AU and 22031126 AU respectively). 
Subsequent hormonal patterns 
The effects of the E -induced gonadotropin surges in the midfollicular phase 
on subsequent hormonal patterns and cycle length were the same for both experi­
ments (Table 7) Therefore, we averaged the results of both experiments and these 
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θ «12 .16 
100 
Fig. 3. The patterns of LH, FSH, E and Ρ during cycles in which two E cap­
sules are inserted at day 7 or 8 (n=14) and a Ρ capsule 24 h thereafter (n=7). 
All capsules are removed 96 h after the implantation of the E capsules (see 
arrow). The first day of menstruation is indicated by "M". For each hormone 
the geometrical mean is represented, except for E for which the mean after a 
square root transformation is represented. Means are given with the 95% confi­
dence limit of the mean (vertical solid lines). The day of the LH and FSH peak 
is taken as the point of reference. The shaded areas are the range of the 
normal values for the presented hormones. 
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pg/ml ·—· 
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Fig. 4. The patterns of LH, FSH, E and Ρ in monkey G37 during a menstrual 
cycle in which two E„ capsules are inserted at day 8 and a Ρ capsule 24 h 
thereafter.. At day 12 all capsules are removed (see arrows). 
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data are presented in Fig. 3. In order to obtain a continous pattern, the con­
cession was made to shift the first 6 days of the experimental cycles 3 days 
to the right, in comparison with the normal cycles. The days -8 to -3 are,in 
fact, the days -11 to -6 of the normal cycles. Furthermore, for reasons of com­
parison, we included only daily values in Fig. 3, although samples were drawn 
and analysed more frequently during the experiment (see also Materials and 
Methods section). Included were the 2, 28, 52, 80, and 100 h sample points. 
In the calculations of the data presented in the Tables 8 and 9, the hormone 
concentrations in the 0 h sample were used to represent day -2. At day +1 the 
steroid capsules were still present, which resulted in artificial steroid le­
vels at day +1. Therefore, day +1 was deleted from our calculations of the 
data in the Tables 8 and 9. Table 7 shows the effects of the experiments on 
some properties of the menstrual cycle. The data in the experimentally short­
ened cycles show a deviation from the normal distribution and therefore, we 
made our comparisons with a nonparametric test. The results show that in all 
but one monkey (monkey no. G37) the length of the follicular phase was short­
ened by 2-4 days. On the average, the length of the luteal phase was not sig­
nificantly different from that observed in the control cycles. A closer ex­
amination reveals that 5 out of 14 luteal phases are too short of length to 
be regarded as normal (monkey no. F4 and 2, both experiments, and monkey no. 
2843, experiment 1). Figure 3 shows that the mean Ρ concentrations are too 
low in these 14 luteal phases. The individual data reveal that the 5 luteal 
phases that were too short of length also did not show a Ρ increment. The 9 
luteal phases with an apparent normal length could be divided into two groups: 
a group with Ρ increments indistinguishable from normal (n=2, monkeys no. 138 
and 2843 in experiment 2), and a group with subnormal Ρ increments (n=7). A 
representative example of the latter group is shown in Fig. 4. The pattern of 
FSH is also different from the pattern observed in normal menstrual cycles. 
In the normal menstrual cycle, FSH reaches its lowest level in the middle 
third of the luteal phase. In these experimentally induced luteal phases, FSH 
levels increase from day +2 onwards to the day before the next menstruation. 
This observation is significantly different from the normal pattern (see Table 
8; FSH, days +2 to +4 vs. +5 to +8 and days +2 to +6 vs. +7 to +11). The 
steady increase of the FSH concentrations can also be established by analyzing 
the correlation between FSH concentrations and the day of the luteal phase 
(Table 9, days VS. FSH, +2 to +15). The pattern of E seems to differ also 
from the pattern observed in the normal menstrual cycle. In the normal cycle 
E- reaches a plateau of ±100 pg/ml in the midluteal phase. In these experiment-
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Table 7. Data of 7 monkeys treated with E (experiment 1) and E +P-Î-24 h (experiment 2) on day 7 or 8 of the cycle. 
Monkey 
(no.) 
2781 
F49 
G37 
2843 
138 
F4 
2 
X+SD 
Length 
(days) 
26 
25 
23 
31 
28 
28 
30 
27.3±2. 
control cy 
F. phase1 
(days) 
11 
11 
9 
13 
12 
11 
14 
8 11.6±1.6 
cle 
L. ph as 
(days) 
15 
14 
14 
18 
16 
17 
16 
15.7±1. 
;e2 
.5 
Length 
(days) 
23 
27 
22 
19 
27 
11 
11 
20±6.83 
experiment 1 
F. phase1 
(days) 
9 
9 
9 
9 
10 
9 
10 
9.3±0.5k 
L. phas 
(days) 
14 
18 
13 
10 
17 
2 
1 
10. 7±6. 
;e2 
,85 
Length 
(days) 
25 
24 
23 
23 
25 
11 
15 
20.9±5.66 
ex 
F. 
iperiment 2 
phase1 
(days) 
9 
9 
9 
9 
9 
9 
9 
9. oto.o1* 
L. phase2 
(days) 
16 
15 
14 
14 
16 
2 
6 
11.9±5.65 
1F. phase = Follicular phase (first day of menstruation to the day of the LH peak). 
2L. phase = Luteal phase (day after the LH peak to the day before the next menstruation). 
3Significantly different from control cycles, two tailed Mann-Whitney U test, P<0.05 
^Significantly different from control cycles, two tailed Mann-Whitney U test, P<0.01 
5Not different from control cycles 
6Significantly different from control cycles, two tailed Mann-Whitney U test, P<0.02 
ally shortened cycles E« increases from day +2 onwards (see Table 9; days ys. 
Ε , +2 to +15) and reaches values of ±100 pg/ml only at the end of the luteal 
phase. 
Table 8. Significance of differences between cycle days of LH, FSH, Estradiol, 
and Progesterone, as established by the calculation of contrasts, and their 
incidence in 14 experimentally shortened menstrual cycles. 
Contrasts between cycle days Hormone F value Significance Incidence 
shortened normal' 
-I- -8 to -2 VS. +2 to +15 LH 0.17 NS. 7 6/103 (12/20) 
t +2 to +9 ys. +10 to +15 LH 0.07 NS. 4/9 3 (ІО/гО)4 
+ -6 to -2 VS. +2 to +8 FSH 6.45 P<0.001 6/103 (11/20)1* 
+ +2 to +4 УЗ. +5 to +8 FSH 2.26 1'<0.01 1/105 (13/20) 
+ +8 to +11 ys. +12 to +15 FSH 1.96 P<0.05 7/9 3 (19/20) 
+ +2 to +6 ys. +7 to +11 FSH 3.46 P<0.001 1/106 (15/20) 
+ +7 to +11 ys. +12 to +15 FSH 2.30 P<0.01 8/9 3 (19/20) 
+ +8 ys. +13 FSH 0.90 NS. 7/9 3 (15/20) 
+ +2 to +6 ys. +7 to +11 E 2 4.09 P<0.001 9/10
3
 (16/20) 
+ +7 to +11 ys. +12 to +15 E 2 7.72 P<0.001 7/9
 3
 (П/гО)1* 
+ +2 to +6 ys. +2 to +15 E 24.06 P<0.001 9/9 3 (18/20) 
+ +2 to +6 ys. +7 to +11 Ρ 28.95 P<0.001 9/103 (19/20) 
t +7 to +11 ys. +12 to +15 Ρ 21.43 P<0.001 8/9 3 (20/20) 
^Data are from Helmond et al. (9). 
Nonsignificant 
Not significantly different from the normal frequency (in parentheses) 
^Nonsignificant observation in 20 normal menstrual cycles 
Significantly different from the normal frequency P=0.0056 
Significantly different from the normal frequency P=0.0011 
The arrow indicates whether the first part of the contrast is higher (+) or 
lower (+) than the second part. 
DISCUSSION 
The hormonal patterns during the menstrual cycle, subsequent to the admini­
stration of estrogens in the follicular phase, were investigated to some extend 
in the human female (1-3). Tsai and Yen found that daily oral administration 
of 200-400 pg ethinyl estradiol on days 3, 4, and 5 of the menstrual cycle in­
duced an LH but not an FSH surge. Furthermore, they found that the treatment 
cycles were significantly prolonged and that this was due to an elongation of 
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Table 9. The correlation between hormones and their incidence in 14 shortened menstrual cycles. 
Correlations between X and Y Incidence of the sign of the r value Sign test Analyzing all pairs 
on the indicated days and its significance in individuals 
X, Days P<0.05 -
10 
5 
11 
1 
0 
1 
1 
0 
7 
4 
P<0.05 
1 
0 
4 
1 
0 
0 
0 
0 
0 
1 
Ρ value 
NS.1 2 
NS. 2 
^<0.053 
Я<0.052 
1'<о.агч 
P<0.053 
P<0.013 
Р<0.02ц 
NS. 3 
NS. 3 
r 
-0.022 
-0.005 
-0.118 
+0.132 
+0.247 
+0.163 
+0.276 
+0.364 
-0.301 
-0.303 
η 
98 
139 
98 
78 
139 
70 
98 
139 
98 
139 
Ρ value 
NS.2 
NS. 2 
NS.3 
NS. 2 
р-^о.ог
1
* 
NS. 3 
P<0.013 
P<0.0011+ 
P<0.013 
P<0.0013 
Days, LH -8 to -2 
+2 to +15 
Days, FSH -8 to -2 
+2 to +8 
+2 to +15 
+8 to +15 
-8 to -2 
+2 to +15 
-8 to -2 
Days, E 
J2' FSH 
FSH +2 to +15 
4 
6 
3 
10 
10 
8 
13 
10 
7 
6 
2 
1 
1 
3 
5 
3 
3 
3 
0 
0 
^ S . = nonsignificant 
Nonsignificant observation in 20 normal menstrual cycles (see ref. 9) 
Significant observation in 20 normal menstrual cycles (see ref. 9) 
Not analysed in 20 normal menstrual cycles (see ref. 9) 
о 
Ui 
Che follicular phase. The last 28 days of these prolonged cycles showed horm­
onal patterns similar to those observed in the control cycles (1). Our find­
ings in the rhesus monkey regarding subsequent hormonal patterns and prolong­
ation of cycle length are quite similar to those of Tsai and Yen. We also 
found that the hormonal patterns during the last 28 days of the prolonged cy­
cles could not be distinguished from those observed in the normal menstrual 
cycle. Yamaji et ai. (5) analysed the subsequent patterns of LH, estrogen, 
and Ρ after an estradiol-benzoate treatment on day 3 of the menstrual cycle 
of the rhesus monkey. These authors found either prolonged cycles, similar to 
our findings, or shortened cycles with a minor Ρ increase subsequent to the 
treatment. Our experiments in the early follicular phase unanimously prolong­
ed the length of the cycle. In our study, shortened cycles were only observed 
after steroid treatment in the midfollicular phase. The different results may 
be due to a different experimental schedule e.g. the higher dosage of estrogens 
used in their study compared to our dosage (750 pg/ml VS. 250 pg/ml). The addi­
tion of Ρ to the estrogens did not alter the sequence of events in our study. 
The treatment cycles remained prolonged. Preliminary data by Clark et al. (6) 
showed that at the end of an estrogen treatment in the follicluar phase of the 
rhesus monkey the follicles had become atretic. We also found that E levels 
were significantly lower after the steroid treatment, indicating atresia of 
follicles. We therefore suggest that after cessation of treatment a new set of 
follicles has to develop. The duration of this process is approximately 18 
days, when the interval between the day of cessation of the treatment and the 
day of the spontaneously gonadotropin surge is taken into consideration. This 
time interval is in good agreement with the suggested duration of follicle 
growth in rodents (10). Our suggested duration of follicle growth in the pri­
mate also supports the hypothesis of Baird et al. (11), who postulated that 
the duration of follicle growth is the same for all species. This duration of 
18 days is at variance with the conclusion of Goodman et al. (12). From their 
experiments (cautery of the dominant follicle in the midfollicular phase), 
they concluded that the interval of 12 days between the cautery of the follicle 
and the day of the spontaneous gonadotropin surge, represents the duration of 
follicle growth in the rhesus monkey. It is, however, doubtful whether follicle 
maturation, after cautery of the follicle, was complete or sufficient since 
the spontaneous gonadotropin surges were followed by luteal phases with de­
creased Ρ concentrations. In 3 out of 8 monkeys the luteal phases were too 
short in length to be regarded as normal. Furthermore, since they removed only 
the so-called dominant follicle, it is possible that other follicles in some 
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stage of development were present in the ovaries. More recent studies by the 
same authors (13-15) support this suggestion, since in these studies the time 
interval between the hemiovariectomy of the side containing the dominant fol­
licle and the day of the spontaneous gonadotropin surge had been increased to 
16 days (range 13-19 days). This latter time interval is in better agreement 
with our observations. It is of interest to note that Goodman et al. (13-15) 
frequently found increased FSH levels after experiments such as follicle cau­
tery, luteectomy etc. This increase in FSH levels was even more marked when 
the contralateral ovary was removed, suggesting between-ovary interactions in 
the monkey. We also found significantly increased FSH secretion after cessa­
tion of the treatment. The subsequent hormonal patterns found by Goodman et dl. 
(13-15) after follicle cautery and contralateral hemiovariectomy, or lute­
ectomy and contralateral hemiovariectomy are quite similar to our findings. 
It is suggested that our experiments affected both ovaries in such a way that 
an eventual between-ovary interaction disappeared and that the growth of a 
new set of follicles has to start all over again. We also found a, not signi­
ficant, tendency towards higher LH levels after our experiments in the early 
follicluar phase. This may be of interest, since a role for small changes in 
tonic LH secretion in determing the growth of the preovulatory follicle in 
rodents has been suggested recently (16). The previously mentioned data by 
Clark et al. (6) showed that atresia of the follicles occurred after admini­
stration of E at day 6 of the menstrual cycle of the rhesus monkey. As a con­
sequence of the E. treatment, they found either prolonged or shortened cycles 
(no hormonal patterns were shown). The reason why the follicles became atretic 
is not clear. In the majority of their experiments and our own, LH and FSH 
surges were induced. LH stimulates the thecal layer of antral follicles to 
produce testosterone (17). This is of interest since androgens probably play 
a significant role in atresia (18-19). However, next to the LH surge also an 
FSH surge was induced. FSH stimulates the granulosa cells and aromatizes test­
osterone to E„ (20). This might explain why an increased E production can be 
observed during the course of our experiments (see Fig. 2). In rats, opposing 
the effect of androgens, estrogens reduce the number of follicles that become 
atretic (18). Therefore, it seems likely that the ratios of androgen to estra­
diol play a significant role in determining the fate of the follicle (19-20). 
An estrogen-induced gonadotropin surge is not a prerequisite for the occurrence 
of a prolonged follicular phase, since in our experiments the blockade of the 
E.-induced gonadotropin surges by luteal levels of Ρ did not alter the sequence 
of hormonal events after cessation of the treatment. Under the latter conditions 
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FSH declined significantly to 50% of the initial values (8) and consequently, 
the intrafollicular ratio of androgens to estradiol may be increased resulting 
in atresia of the follicles (19-20). However, further investigations have to 
be performed in order to explain the mechanism by which atresia occurs, espe­
cially since many of the afore-mentioned data were obtained in rodents and a 
difference between rodents (polyovulators) and primates (monoovulators) with 
respect to e.g. selection of the dominant follicle is not unlikely. The effects 
of the experimentally induced gonadotropin surges in the midfollicular phase 
on cycle length were quite different from those observed after steroid treat­
ment in the early follicular phase. Now the length of the menstrual cycle was 
significantly shorter than in the control cycles. This was mainly due to an 
experimentally shortened follicular phase. At this time (day 7 or 8 of the 
menstrual cycle) it is possible to identify the dominant follicle (21). Recent 
observations by diZerega and Hodgen (22) showed that the first selective bind­
ing properties of hCG to the thecal layer of the dominant follicle in the rhe­
sus monkey occurred also at this time of the cycle. So,a different response 
of the ovary to an endogenous gonadotropin surge in this stage of the cycle, 
when compared with an earlier stage, may be expected. The gonadotropin surges 
were now followed by either luteal phases with normal length and normal Ρ pat­
terns (n=2) or luteal phases with normal length but subnormal Ρ patterns (n=7) 
or by luteal phases too short in length to be considered as normal, without 
substantial Ρ increments. Thus, a variety of effects is possible on subsequent 
luteal phases. These effects are probably related to the individual state of 
maturity of the follicle. Besides P, the patterns of FSH and E were also dif­
ferent in these luteal phases. FSH values did not reach a luteal nadir in the 
middle third of the luteal phase. E values did not reach a plateau of about 
100 pg/ml in the middle third of the luteal phase but reached these values at 
the end of the luteal phase only. Furthermore, FSH levels in the first part of 
these luteal phases were significantly lower than those in the last part of 
the follicular phase. FSH levels in these parts of the cycle are not signifi­
cantly different from the normal menstrual cycle (9). These experimentally 
altered luteal phases were induced by evoking a premature gonadotropin surge. 
This premature gonadotropin surge acts on immature follicles. In this stage of 
the cycle (day 7 or 8), the duration of the action of E_ and FSH on the devel­
oping follicle is still too short in time to induce a sufficient amount of LH 
receptors within the dominant follicle (21). If, in response to the premature 
gonadotropin surges, an (immature) oocyte is released, it is unlikely that the 
corpus luteum, due to an inadequate amount of LH receptors, will secrete a 
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sufficient amount of progesterone. The etiology of luteal phase defects in the 
human has been a topic of research for years (23-25). In the rhesus monkey, 
short luteal phases have been identified in the initial cycles after the onset 
of puberty (26). In mature female rhesus monkeys luteal phase defects have 
been related to inappropiate FSH/LH ratios (27-28). Recently, inappropiate 
FSH/LH ratios have been induced experimentally by the administration of char-
coal-extracted porcine follicular fluid, in the early follicular phase of the 
rhesus monkey (29). This treatment resulted in an induction of luteal phase 
defects and it was concluded that the reduced FSH levels, in combination with 
reduced E levels, resulted in incomplete differentation of luteal cells and 
the presence of a gonadotropin insensitive corpus luteum during the luteal 
phase. From our study, we concluded that not only reduced FSH levels in the 
follicular phase can be related to luteal phase defects but also that too short 
a duration of appropiate FSH levels can evoke luteal phase defects in the 
rhesus monkey, probably by the same mechanism of action as suggested by 
Stouffer and Hodgen (29). We did not perform morphological or histological 
examinations of the ovary during or subsequent to our experiments in this 
study. This will be a subject of future investigations with regard to this 
topic. Our study shows that it is possible to dissociate prolonged and short-
ened cycles by the disparate effects of steroids in the early and midfollicu-
lar phase and that follicle growth can be modified experimentally by changing 
the timing of the gonadotropin peaks. 
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SUMMARY 
The rhesus monkey (Maoaoa mulatta) was used as a model for endocrinological 
investigations into the regulation mechanisms of the menstrual cycle, because 
its menstrual cycle closely resembles the menstrual cycle of the human female 
with respect to its length (28 days) and hormonal course. First of all, radio­
immunoassays (RIAs) for the determination of the pituitary hormones of the 
rhesus monkey, viz. luteinizing hormone (LH) and follicle-stimulating hormone 
(FSH) were set up. Then, RIAs to determine the ovarian steroid hormones viz. 
estradiol (E.), progesterone (P), 17a-hydroxyprogesterone (170HP), and 20a-
dihydroprogesterone (20DHP) were set up. 
Chapter I describes the time course of LH, FSH, E , and Ρ serum concentrations 
in 20 menstrual cycles. At the same time, the daily values of 170HP and 20DHP 
were measured in 5 menstrual cycles. A statistical analysis of the results of 
the LH, FSH, E-, and Ρ measurements shows that LH, FSH, and Ρ values are log-
normally distributed and that the E values are normally distributed after a 
square-root transformation. The range of the normal values of the preceding 
hormones was calculated with the aid of the transformed data. The results show 
that the hormonal patterns during the follicular phase and the periovulatory 
period are in good agreement with those observed in the human female. The hor­
monal profiles in the luteal phase are seemingly different: the midluteal in­
crease of the steroid hormones is less marked than in the human female and 
probably as a consequence of these lower steroid secretions,the gonadotropin 
secretion seems to be relatively higher in the luteal phase than compared to 
human data. A further analysis taught among other things that Ρ is significant­
ly increased at the day of and at the day before the LH peak with respect to 
the previous days. The influence of this Ρ increase on the midcycle LH and FSH 
peak was further investigated in the chapters II, III, and IV. This is possible 
by mimicking the midcycle hormonal events in the early follicular phase, by ex­
ogenous administration of steroids (sc implantation of Silastic capsules). 
From the results in chapter II it appears that P, after an adequate E_ priming, 
is able to advance, to increase, and to narrow the E -induced gonadotropin 
peak. In other words: Ρ accelerates the discharge of LH and FSH from the pi­
tuitary. 
The results in chapter III show that this facilitating effect can be brought 
about by every Ρ concentration (1-20 ng/ml). When Ρ is administered at the 
same time as E this effect is totally different: at a low Ρ concentration 
(1 ng/ml) there is still an advancement, but peaks are lower than with E, 
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alone. This decreasing effect is strongly enhanced with increasing Ρ concen­
trations . 
In chapter IV, it was investigated how specific the facilitating effects of Ρ 
are, by studying the effects of androstenedione, 170HP, and 20DHP in the same 
test system as for P. From the results, it appears that only 170HP can advan­
ce to some extend the LH and FSH peaks and that the combination of the facili­
tating effects of Ρ (advancing, increasing, and narrowing of the gonadotropin 
peak) are specific for P. 
In chapter V, the effects of the afore-described experiments (a steroid in­
crease in the early follicular phase for 96 h) were investigated with regard 
to subsequent hormonal patterns and cycle length. The length of the experiment 
tal cycle has increased by 13 days. This increase in cycle length appears to 
be caused by a prolongation of the follicular phase, which may be caused by 
the disruption of the follicle maturation (atresia) during the course of the 
test. The growth of a new set of follicles has to start all over again and 
will last presumably 18 days. The last 28 days of the prolonged menstrual cy­
cle showed hormonal patterns identical to those observed in the normal mens­
trual cycle. A similar experiment (a steroid increase for 96 h) performed in 
the midfollicular phase, when the follicles have developed somewhat more, 
shows that the E -induced gonadotropin surges are followed by luteal phases 
with either a normal length and a normal Ρ increment (n=2), or a normal length 
but a subnormal Ρ increment (n=7), or a very short length, without a Ρ incre­
ment (n=5). To influence follicle growth and corpus luteum function in a way 
as described above, offers interesting possibilities to study the follicle 
growth and atresia as well as the origination of an inadequate luteal phase 
in the primate. 
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SAMENVATTING 
De rhesus aap (Macaca mulatta) werd als model gebruikt voor endocrinologisch 
onderzoek naar de regulatie mechanismen van de menstruele cyclus, omdat de 
cyclus van de rhesus aap qua lengte (28 dagen) en hormonaal verloop veel lijkt 
op die van de mens. Ten behoeve van het onderzoek zijn allereerst radioimmuno-
logische bepalingen (RIA's) opgezet voor de hypofysaire hormonen van de rhesus 
aap namelijk,het luteinizerende hormoon (LH) en het follikel-stimulerende hor-
moon (FSH). Vervolgens zijn ook RIA's opgezet voor de volgende ovariële steroid 
hormonen: oestradiol (E,), progesteron (P), 17ai-hydroxyprogesteron (170HP), 
en 20a-dihydroprogesteron (20DHP). 
Hoofdstuk I beschrijft het verloop van de LH, FSH, E 9, en Ρ serum concentraties 
in 20 menstruele cycli. Tevens zijn in 5 cycli de dagelijkse waarden van 170HP 
en 20DHP bepaald. Een statistische analyse van de resultaten van de LH, FSH, 
E , en Ρ bepalingen laat zien dat de LH, FSH, en Ρ waarden lognormaal verdeeld 
zijn en dat de E waarden na wortel-transformatie normaal verdeeld zijn. Met 
behulp van deze gegevens zijn de normaal waarden van de betreffende hormonen 
berekend. De resultaten laten zien dat het hormonale verloop, tijdens de fol-
likulaire fase en de periovulatoire periode, goed in overeenstemming is met 
het verloop zoals dat bij de mens wordt waargenomen. De hormonale profielen 
tijdens de luteale fase lijken anders te verlopen: de midluteale stijging van 
de steroid hormonen is niet zo uitgesproken als bij de mens en mogelijk is, 
als een consequentie van deze verlaagde steroid produktie, de gonadotropine 
secretie in de luteale fase van de rhesus aap relatief hoger dan bij de mens. 
Een verdere analyse leerde, onder andere, dat Ρ op de dag van en op de dag 
voor de LH piek significant verhoogd is ten opzichte van de voorafgaande da­
gen. In de hoofdstukken II, III, en IV wordt beschreven hoe deze Ρ stijging 
de midcyclische gonadotropine piek kan beïnvloeden. Dit is mogelijk door het 
hormonale midcyclische gebeuren in de vroeg follikulaire fase te imiteren. 
Dit gebeurde door exogene toediening van Steroiden (sc implantatie van Silastic 
capsules). 
De resultaten van hoofdstuk II laten zien dat P, na voldoende voorbereiding 
met E , de door E geïnduceerde LH en FSH pieken kan vervroegen, verhogen, en 
versmallen, met andere woorden, Ρ versnelt de uitstorting van LH en FSH uit 
de hypofyse. 
De resultaten uit hoofdstuk III tonen aan dat dit faciliterende effect door 
alle Ρ concentraties (1-20 ng/ml) bewerkstelligd kan worden. Indien Ρ tege­
lijkertijd met E wordt toegediend, is het effect heel anders: nu treedt er 
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met een lage Ρ concentratie nog wel een vervroeging op, maar de pieken zijn 
lager dan met E alleen. Dit verlagende effect neemt sterk toe met stijgende 
Ρ concentraties. 
Hoofdstuk IV beschrijft hoe specifiek het faciliterende Ρ effect is, door in 
een zelfde testsysteem als voor Ρ de effecten van androsteendion, 170HP en 
20DHP te bestuderen. Uit de resultaten blijkt dat alleen 170HP de LH en FSH 
pieken kan vervroegen, maar dat de combinatie van faciliterende Ρ effecten 
(vervroegen, verhogen, en versmallen van de LH en FSH piek) specifiek is voor 
P. 
Hoofdstuk V beschrijft het gevolg van de hierboven genoemde experimenten (een 
steroid verhoging in de vroeg follikulaire fase gedurende 96 h) voor het hor­
monale verloop en de lengte van de menstruele cyclus. Het blijkt dat de lengte 
van de experimentele cyclus met 13 dagen is toegenomen. Dit wordt veroorzaakt 
door een verlenging van de follikulaire fase. Deze verlenging van de folliku­
laire fase is mogelijk het gevolg van het ten gronde gaan van de follikels 
(atresie) onder invloed van de test. Na afloop van de test moet de follikel 
groei weer helemaal opnieuw beginnen en duurt dan 18 dagen. De hormoon waarden 
tijdens de laatste 28 dagen van de verlengde cyclus zijn identiek aan die in 
de normale cyclus. Eenzelfde soort experiment in de midfollikulaire fase, als 
de follikels wat verder ontwikkeld zijn, laat zien dat de geïnduceerde LH en 
FSH pieken gevolgd worden door luteale fasen met een normale lengte en een 
normale Ρ stijging (n=2), of een normale lengte met een subnormale Ρ stijging 
(n=7) of door een luteale fase die te kort van lengte is en die geen Ρ stijg­
ing laat zien (n=5). De beïnvloeding van de follikel groei en corpus luteum 
functie op een manier als hierboven is beschreven, biedt interessante mogelijk-
heden tot het bestuderen van de groei en atresie van follikels en het ontstaan 
van een inadequate luteale fase bij de primaat. 
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STELLINGEN 
1. Progesteron heeft een positief effect op de door oestradiol geïnduceerde 
afgifte van LH en FSH uit de hypofyse. 
2. Progesteron heeft een negatief effect op de door oestradiol geïnduceerde 
afgifte van LH en FSH uit de hypofyse. 
3. De uitspraak van Knobil "Als progesteron al in staat is om de door 
oestradiol geïnduceerde gonadotropine pieken te modificeren, dan moet 
dit wel een heel subtiel effect zijn" wordt in dit proefschrift bevestigd. 
- E Knobil 1974 Ree Prog Hortn Res 30:1 
4. De conclusie van Goodman et at. dat de duur van de follikel rijping bij 
de primaat 12 dagen is, wordt niet voldoende ondersteund door hun 
experimenten. 
- AL Goodman et al. 197 7 Endocrinology 100:155 
5. De duur van de follikel rijping is voor alle species hetzelfde en bedraagt 
ongeveer 18 dagen. 
- DT Baird et al. 1975 J Reprod Fértil 45:611 
6. Voordat aan het voorkomen van onbezette receptoren voor oestradiol in 
kernen van doelwit cellen betekenis toegekend mag worden, dient uit-
gesloten te zijn dat hun aanwezigheid berust op technische onvolkomen-
heden bij de zuivering van die kernen. 
- DP Edwards et al. 1980 Exp Cell Res 127:197 
7. Het leren te studeren is nog steeds een sterk verwaarloosd onderdeel van 
vele studierichtingen. 
8. De keuze mogelijkheid van de werkende zwangere vrouw om na de bevalling 
al of niet te blijven werken wordt ernstig belemmerd door een gebrek aan 
opvang mogelijkheden voor de boorling. 
9. De verplichte jaarlijkse stijging van het defensie budget met 3% dient 
herzien te worden in het kader van de voorgenomen bezuinigingen op de 
overhe ids ui tgaven. 
10. Het vervangen van woningen door parkeergarages is in tegenspraak met de 
huidige maatschappelijke behoefte aan meer woonruimte en de huidige 
economische ontwikkeling die tot een verlaagd bestedingspatroon van de 
consument zal leiden. 
11. El Salvador. What's in a name. 
12. De conclusie van Broadbent dat Chateau du Bousquet 1975 een wijn "for 
quaffing" is, vloeit voort uit een overschatting van de smaak en van 
de beurs van de gemiddelde wijn consument. 
- M Broadbent 1980 The great vintage wine book,page 150 
13. De hoogte van het ELO getal van een schakende promovendus is omgekeerd 
evenredig met de duur van de promotiestudie. 
14. De laatste stelling van een schaakpartij geeft niet altijd aanleiding 
tot vreugde. 
F.A. Helmond Nijmegen, 1 mei 1981 


